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Abstract 
Four experiments were performed in a greenhouse or growth chamber to study the 
quantity and quality of flavonolignans in response to environmental stress in milk thistle 
(Silybum marianum L., Gaertn.).  A preliminary experiment was conducted in spring 
2004 to study effects of leaf harvests on growth, development, and flavonolignan content 
in milk thistle seeds.  Taxifolin, a component of silymarin and precursor to 
flavonolignans, was significantly reduced due to leaf harvest treatments. 
The weedy nature (sporadic germination) of Silybum made germinating enough 
plants for experimentation problematic.  Initial germination studies to determine 
imbibition and pre-chilling requirements were inconclusive due to heavy fungal 
infections.  A sterilization procedure was chosen to treat seeds before experimental use 
and flavonolignan analysis.  Germination trials were also performed with seven other 
seed sources.  Seeds harvested in Croatia showed the best germination and were used for 
subsequent experiments.     
Flavonolignans in Silybum seeds are reported to vary depending on environmental 
conditions and genetic diversity within a population.  In another experiment, total 
silymarin concentrations determined from eight seed sources from around the world 
ranged from 29.6 to 56.9 mg/gram of seed meal.  Individual flavonolignans varied 
significantly in and among seed sources.   
In the first stress experiment was, plants were grown in pine bark media in 
polyethylene bags.  Plant densities from 1-24 plants/bag were established.  Immature and 
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total seed counts and yields decreased with increasing density.  Number of blooms per 
plant, bloom diameter, and mature seed count and yield were negatively correlated to 
density.  There was no significant effect of plant density on flavonolignan content. 
In the second stress experiment, milk thistle plants were grown in perlite in 
polyethylene bags.  Water treatments (200, 650, 1100, 1550, and 2000 mL/day including 
fertigation) were created using pressure-compensated emitters.  The lowest watering rate 
significantly reduced stem height and bloom diameter.  The highest water treatment 
showed the highest count of immature seeds.  In primary blooms, the lowest water rate 
yielded the highest taxifolin concentration (0.89 mg/g).  Flavonolignan content was not 
significantly affected in secondary blooms.   
Silybum growth and development was affected by environmental stress.  
However, no significant effect on silymarin concentration or composition was 
established. 
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I. Introduction 
Plants produce a number of secondary metabolite compounds that are not 
involved in primary metabolic processes (such as photosynthesis, transpiration, and 
respiration).  While first thought to be waste products, in reality these compounds serve 
various important roles within the plant.  Some compounds provide protection for the 
plant against herbivory and insect or pathogen attack, while others attract pollinators or 
function allelopathically to decrease competition with other plants (Hadacek, 2002).   
Secondary metabolites are of great interest not only because of their unique functions 
within plants themselves, but also for their potential impact on human health.  Many 
secondary metabolites, which function for protective purposes in plants, exhibit 
antimicrobial or medicinal properties (Bourgaud et al., 2001).  Since recorded history, 
man has recognized these compounds’ characteristics and has used plants for a variety of 
medicinal uses.  The levels of secondary metabolites produced in plants can be 
environmentally as well as genetically controlled (Singh et al., 2003). 
Silybum marianum (L.) Gaertner, also known as milk thistle, is a medicinal plant 
containing hepatoprotectant flavonolignans.  The flavonolignans in Silybum that exhibit 
these medicinal properties are collectively known as silymarin.  Originally, silymarin was 
thought to be one large, complex molecule.  However, in 1974, it was found that 
silymarin is actually a mixture of several flavonolignans (Wagner, 1974).  
Flavonolignans are formed through the free-radical oxidative coupling of the flavonoid 
dihydroquercetin (also called taxifolin), and coniferyl alcohol (a component of lignan) 
  
 
2
(Kim et al., 2003; Kurkin, 2003).  This reaction forms silybin, thought to be the most 
bioactive component of silymarin, and a mixture of regioisomers and diastereomers 
(Kurkin, 2003).  The three main flavonolignans in Silybum are silybin (also referred to as 
silybinin), silychristin and silydianin.  Furthermore, diastereomers of silybin (silybin A 
and B) have been isolated, as well as the regioisomers of silybin, isosilybin A and B (Lee 
and Liu, 2003).  Most recently, a diastereomer of silychristin (now known as silychristin 
A) was discovered and referred to as silychristin B (Martin et al., 2006).  Structures of 
these compounds can be seen in Figure A-1 (refer to Appendices for all tables and 
figures).  Other minor compounds include dehydrosilybin, desoxysilychristin, 
desoxysilydianin, silybinome, isosilychristin, silymonin, silandrin, silyhermin, and 
neosilyhermins A and B.  These compounds are found throughout the plant, but are most 
concentrated in the seeds.  The compounds found in Silybum can act to prevent liver 
problems, as well as treat acute liver poisoning or chronic disease.  Investigations have 
also been made into the use of milk thistle for treating various types of cancer, controlling 
cholesterol, promoting nerve system health, and regulating blood sugar in those with type 
II diabetes.    
The objectives of this research were to determine the individual effects of 
population density and water stress on growth, yield, and the quality and quantity of 
flavonolignans produced in milk thistle. 
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II. Literature Review 
Overview of secondary metabolites 
Plants produce a number of secondary metabolic compounds that are not involved 
in primary metabolic processes (photosynthesis, transpiration, respiration).  These 
compounds are formed via biochemical pathways that diverge from primary plant 
metabolism.  While first thought to be waste products, in reality these compounds serve 
various important roles within the plant.  Many times these compounds provide 
protection for the plant against herbivory and insect or pathogen attack. Others functions 
are to attract pollinators or work allelopathically to decrease competition with other 
plants (Hadacek, 2002).  Secondary metabolites can also protect the plant against UV 
radiation and damage.  Others function in overflow storage or disposal of waste products 
from primary metabolism or are recycled into primary metabolism during leaf 
senescence. (Wills et al., 2000)  These compounds are essential for plant survival and 
reproductive success.   
The levels of secondary metabolites produced in plants can be environmentally as 
well as genetically controlled (Singh et al., 2003).  Secondary metabolites also indicate 
differentiation between plant families.  For example, Lamiaceae, the mint family, 
contains iridoids and essential oils that are not common in other families.  Solanaceous 
plants contain tropane and steroidal alkaloids.  These biochemical variations among plant 
families and genera can be attributed in part to phylogenetic and ecological influences.  
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The development of these different combinations of secondary metabolites in plants has 
allowed adaptation to and in the environment. (Wink, 2003)   
Secondary metabolites are of great research interest not only because of their 
unique functions within plants themselves, but also for their potential impact in human 
health.  Many secondary metabolites that exhibit antimicrobial or medicinal properties 
function for protective purposes in plants. (Bourgaud et al., 2001)  Most 
pharmacologically active secondary plant metabolites are generated from the shikimate, 
acetate-malonate, and acetate-mevalonate pathways.  Classes of these compounds include 
terpenoids (like saponins, carotenoids, and steroids), phenolics (like flavonoids, tannins, 
quinines, salicylates, and lignins), alkaloids, polysaccharides, and peptides.  Essential oils 
and resins are also important and often contain chemicals from multiple classes of 
secondary metabolites. (Wills et al., 2000)  Man has historically recognized these 
compounds’ characteristics and has used plants containing them for medicinal purposes.  
Many secondary metabolites are still under-researched as to their potential as medicines 
(Singh et al., 2003; Wills et al., 2000).   
Medicinal Plants (general) 
 Written documents from early Chinese, Indian, and Near East cultures indicate 
the use of plants as medicine spanning back at least 5,000 years.  Perhaps plants have 
provided medicine for humans as long as the species has existed. (Hamburger and 
Hostettmann, 1991)  Today, many commercial drugs have their basis in compounds 
discovered in plants.  Plants still contain vast potential for the basis of new synthetic 
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drugs, as well as the use of the whole plant or plant parts themselves as medicine.  The 
past 50 years have seen a great increase in analytical scientific methods for the 
investigation of the constituents and biological activity that is found in medicinal plants.  
Ethnopharmaceutical and ethnobotanical studies have increased anthropogenic 
inspiration for scientific research into the efficacy of these beneficial plants.  
Chromatographic (TLC, GC, HPLC), spectroscopic (UV, IR, 1H- and 13C-NMR, MS), 
and biological (various bioassays) techniques are used in the growing area of medicinal 
plant research.  Plants that have received research attention in recent years have 
demonstrated anticancer, anti-inflammatory, immunostimulatory, antimicrobial, and 
antibiotic properties; furthermore, the potential for continued validation and discovery of 
herbal preparations necessitates further research (Phillipson, 2003). 
 In Germany, the widespread research and use of medicinal plant preparations 
(also termed phytopharmaceuticals or phytomedicines) have been common since the 
1980’s.  Over 300 clinical studies used standardized phytopharmaceuticals, including 
Silybum, Echinacea, Aesculus, Hypericum, Ginkgo, Valeriana, Allium sativum, Viscum, 
Sabal, Urtica, Crataegus, and Kava-Kava.  These studies investigated the use of these 
preparations for the treatment of moderate or moderately severe diseases and for the 
prevention of disease.  Several of the clinical trials showed that the herbal preparations 
had full therapeutic equivalence with synthetic drugs without adverse side-effects.  The 
action of plant extracts vary greatly from the drugs used to treat the same ailments.  The 
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action of the herbal preparations can be characterized as polyvalent, and interpreted as 
additive or even potentiating. (Wagner, 1999) 
 Synergistic interactions that occur between compounds in herbal preparations or 
phytomedicines are of great importance.  Synergism often explains the efficacy of a 
preparation, especially when needed in only small doses.  The bioactivity, or efficacy, of 
one compound in an herbal mixture often decreases when isolated from the mixture.  This 
is true both in single-plant preparations as well as phytomedicines containing more than 
one plant.  The use of whole or partially purified extracts containing multiple active 
ingredients is essential to the philosophy of herbal medicines. (Williamson, 2001) 
Modern Opinion 
 The medicinal use of herbs by numerous cultures can be found throughout 
history.  On the North American continent, Native Americans used various herbs for 
antifungal, bactericidal, larvicidal, and molluscicidal properties.  Extracts of nineteen 
plants with reported Native American use were screened for these various bioactivities.  
Plants demonstrating bioactivity included Actaea pachypoda, Actaea rubra, Apocynum 
androsaemifolium, Aralia hispida, Asarum canadense, Caulophyllum thalictroides, 
Gaultheria procumbens, Geocaulon lividum, Ledum groenladicum, Pyrola elliptica, 
Sambucus canadensis, Scutellaria epilobifolia, Scutellaria lateriflora, Sorbus americana 
(Bergeron et al., 1996).  Moreover, many of the native herbs that are commercially 
available today were used by Native Americans for similar purposes.  Seven of the top 
ten most commonly sold herbal supplements in the United States were employed by 
Native Americans.  These plants include ginseng (Panax quinquefolius, P. ginseng, 
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Eleutherococcus senticosus), garlic (Allium sativum), Echinacea (Echinacea purpurea, 
E. angustifolia, E. pallida), goldenseal (Hydrastis canadensis), St. John’s wort 
(Hypericum perforatum), evening primrose (Oenothera biennis), and cranberry 
(Vaccinium macrocarpon). (Bergeron et al., 1996; Borchers et al., 2000) 
Much of the world, especially developing countries, still depends on traditional 
medicine or a mix of traditional and Western medicine for the treatment of medical 
problems.  However, there has been a limited amount of interaction and research 
performed to evaluate and compare Western and traditional medicines.  The perception 
by Western medical practitioners that traditional or herbal medicine is not founded in 
science dominates.  Nevertheless, interest in herbal medicine is growing along with the 
need for Western methodologies to discover new, effective drugs.  As was done in the 
development of early drugs, researchers are investigating to plants as a source of 
medicinal secondary metabolites in an attempt to isolate novel compounds. (Taylor et al., 
2001) 
 There are several reasons that the population at large is becoming more interested 
in natural remedies and herbal medicine.  First, consumers are interested in a more 
natural way of life.  As the world around us becomes more complex, more people desire 
to return to their proverbial roots.  There has also been an increase in dissatisfaction 
among consumers toward modern health care because of expense, undesirable or 
dangerous side effects, and ineffectiveness.  Finally, as Americans have more leisure 
time, more time is spent on one’s health and fitness, especially in a society where aging 
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baby boomers are becoming more concerned with prolonging their health and active 
lifestyles. (Brevoort, 1996) 
 Complementary/alternative medicine (CAM) includes not only herbal medicine, 
but also treatments such as acupuncture, reflexology, and chiropractic care.  Three 
surveys performed in recent years show an increase in use of CAM and an insignificant 
increase in healthcare professionals use and knowledge about CAM, specifically herbal 
and dietary supplements.  In a 2003 study, Madsen et al. conducted a survey of pediatric 
patients (age 0-18) profiling CAM use in Denmark.  Fifty-three percent of those 
interviewed had used CAM at least once, and 23% had tried CAM within the last month 
(15% of that consisting of herbal medicines).  Fifty percent of patients had experienced 
positive effects, with 6% reporting side effects of treatment.  The authors note that their 
results of 53% of interviewees reporting CAM use is higher than reported in previous 
Danish studies and studies from other countries. 
 Kemper et al. (2003) performed a cross-sectional survey of healthcare 
professionals in the Boston, MA area including physicians (MD), advanced practice 
nurses (RN), pharmacists (PharmD), and dietitians (RD).  66% of those interviewed 
reported receiving professional education about herbs and other dietary supplements 
(H/DS) in the past year.  However, on the questionnaire about H/DS remedies, the 
highest scoring group (dietitians) scored an average of less than 60% of possible points.  
Despite the growing knowledge and interest of the consumer/patient for herbal therapies, 
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this study indicates that most health care professionals do not have adequate knowledge 
of or interest in herbs or other dietary supplements. 
 A 2007 survey at Georgetown University School of Medicine in Washington D.C. 
evaluated first- and second-year medical students’ attitudes toward CAM in their medical 
school curriculum and in their future practice  In this study, CAM included acupuncture, 
herbal medicine, nutritional supplements, biofeedback, bioelectromagnetic therapies, 
aromatherapy, homeopathy, chiropractic, massage, hypnosis/guided imagery, music, 
prayer/spiritual healing, Rolfing (structural reintegration), therapeutic touch and 
meditation.  Students indicated that in 11 these of 15 modalities the desired level of 
training was “sufficient to advise patients about use,” (Chaterji et al., 2007).  The 
researchers found that 91% of students agreed that Western medicine could benefit from 
ideas and methods included in CAM.  More than 85% agreed that “knowledge about 
CAM is important to me as a student/future practicing health professional,” and more 
than 75% of students thought that CAM should be included in the curriculum (Chaterji et 
al., 2007).  The highest level of interest was in acupuncture, chiropractic, herbal 
medicine, and nutritional supplements.  While the students showed interest and 
enthusiasm toward CAM, personal experience in the survey group was not highly 
prevalent. (Chaterji et al., 2007) 
 Another problem with herbal medicine currently is the lack of standardization.  
This is especially important when considering the increase in self-medication among 
individuals who choose to use alternative medicines. (Elvin-Lewis, 2001)  Compounding 
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the lack of standardization problem is the lack of risk-benefit profiles for herbal 
preparations.  Risk-benefit profiles can be created by systematic reviews of controlled 
clinical trials published using herbal medicines.  These profiles include information on 
any adverse side-effects of herbs as well as any known contraindications with 
prescription drugs. (Ernst, 2002) 
 Pharmacovigilance is defined as, ‘the study of the safety of marketed drugs under 
the practical conditions of clinical usage in large communities,’ (Mann and Andrews, 
2002).  Pharmacovigilance practices are developed to control the safety and good 
manufacturing practices for pharmaceutical drugs.  Such standards also need to be 
established for herbal preparations.  In addition to risk-benefit profiles, 
pharmacovigilance monitors adverse drug reactions and responds to and communicates 
drug safety concerns.  These practices can assist in developing standard methods of 
handling plant material for medicine.  This is extremely important because the quality 
and quantity of medicinal components in plants can be affected by factors including inter- 
or intraspecies variation, environmental factors (climate, growing conditions), time of 
harvest (can even vary depending on the time of day), and post-harvest factors (storage, 
drying, etc.). (Barnes, 2003) 
 Another important consideration in the use of herbal medicine is potential adverse 
interactions with prescription and over-the-counter drugs.  For example non-steroidal 
anti-inflammatory drugs (NSAIDs), like aspirin, have the potential to increase the risk of 
bleeding when taken with herbs that possess antiplatelet activity (such as ginkgo, willow, 
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ginger, and garlic)  or that contain coumarin (like chamomile and horse chestnut).  
Further, acetaminophen when taken with ginkgo can also increase the risk of bleeding 
because of decreased platelet aggregation.  On its own, acetaminophen has hepatotoxic 
properties, and can cause severe liver damage when taken with herbs, like kava-kava and 
Echinacea, that can cause stress to the liver.  Nephrotoxicity is also possible when 
acetaminophen is taken concomitantly with herbs containing salicylate, like willow and 
meadowsweet. (Abebe, 2002) 
 Certain herbs can also decrease the effectiveness of prescription drugs.  For 
example, St. John’s Wort (Hypericum perforatum) lowers blood concentration of 
amitriptyline, cyclosporine, digoxin, indinavir, phenprocoumon, theophylline, and 
warfarin.  When St. John’s Wort is taken concomitantly with oral contraceptives 
(ethinylestradiol/desogestrel), loperamide, or selective serotonin-reuptake inhibitors 
(SSRIs), intermenstrual bleeding, delirium, or mild serotonin syndrome can occur. (Izzo 
and Ernst, 2001)  These sorts of interactions and contraindications are critical to consider 
when one chooses to pursue herbal medicine for treatment. 
 Many medicinal herbs contain antimicrobial properties.  One consideration in 
using these products is the possibility of increased antibiotic resistance.  Ward et al. 
(2002) studied the effects of different herbal and nutraceutical products on antibiotic 
resistance in gram positive and gram negative bacteria.  The minimum inhibitory 
concentration (MIC) of antibiotics (ampicillin) applied to the bacteria were recorded in 
the presence of the various nutraceuticals preparations.  Thirteen of the preparations 
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resulted in an increase in MIC, two preparations showed decreases, and seven had no 
changes.  Garlic, Echinacea, and zinc products all caused large increases in MIC. 
 Despite the possible negative or tedious aspects of taking and/or working with 
herbal preparations, medicinal phytochemicals can demonstrate several different modes 
of health benefits including the following: substrates for biochemical reactions; cofactors 
of enzymatic reactions; inhibitors of enzymatic reactions; absorbents or sequestrants that 
bind to and eliminate undesirable constituents in the intestine; ligands that agonize or 
antagonize cell surface or intracellular receptors; scavengers of reactive or toxic 
chemicals; compounds that enhance the absorption and or stability of essential nutrients; 
selective growth factors for beneficial gastrointestinal bacteria; and selective inhibitors of 
deleterious intestinal bacteria (Dillard and German, 2000). 
Silybum – Taxonomy & Culture 
 Silybum marianum (L.) Gaertner (formally known as Carduus marianus L.) is 
classified as follows: Kingdom Plantae, Division Magnoliophyta, Class Magnoliopsida, 
Order Asterales, Family Asteraceae, Tribe Cardueae.  Silybum can be referred to by the 
common names milk thistle, variegated thistle, wild artichoke, lady’s thistle, holy thistle, 
Mary thistle, Marian thistle, and St. Mary’s thistle.  Several of these common names arise 
from the morphology and legend of the plant.  Marbled white venation occurs on the 
leaves.  According to ancient legend, the white venation arose after being touched by the 
Virgin Mary’s milk, which also corresponds with the plant’s historical use as a 
galactogogue.  There are two species in the genus Silybum, the purple flowered S. 
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marianum and the white flowered S. eburneum Coss. et Durieux.  Both species produce 
hepatoprotectant flavonolignans (McKenna et al., 2002).  In a genetic study, German 
researchers concluded that S. eburneum is really a variation of S. marianum, as opposed 
to being a distinct species (Hetz et al., 1995). 
 Milk thistle grows as an annual or biennial, depending on climate.  Leaves are 
large, typically growing 10 cm in width and 30 to 40 cm in length.  They are obovate 
with a cuneate base and undulate, spinose-dentate margins.  The leaves are typically a 
dark, glossy green with white marbling on the veins.  Spines, whose size ranges from 1 to 
3 cm, are found both on the leaves and on the seed heads.  In the vegetative stage, 
Silybum grows in a basal rosette 0.75 to 2 m in diameter.  Flowers arise on stems which 
can reach 1 m in height in pot production; however, in natural settings milk thistle can 
grow taller.  The flowers of Silybum are light purple to reddish-purple and range from 2.5 
to 6 cm in diameter.  The number of flower heads per plant varies greatly, with 9 to 50 
flowers being produced on average.  Milk thistle seeds grow between 0.5 and 0.8 mm 
long, and are wind-dispersed over short distances via 1 to 2 cm pappus crowns.  A single 
seed head can produce around 100 seeds (Bean, 1985; Morazzoni and Bombardelli, 
1995).  Milk thistle in the wild has the potential to give rise to an average of 55 seed 
heads that can produce some 6,350 seeds per plant (Dodd, 1989). 
Ecology & Control 
 Milk thistle is native to the Mediterranean, and is widespread throughout Europe.  
The literature describes milk thistle as synanthropic, or growing in human habitats (Danin 
and Yom-Tov, 1990).  Wastelands, roadsides, and cultivated ground are all likely places 
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to find milk thistle.  Areas ranging from the coast to sub-mountainous areas can be 
populated by Silybum, with it growing in altitudes of 700 to 1,100 m (McKenna et al., 
2002; Morazzoni and Bombardelli, 1995).   
Scientists in Israel have documented seed dispersal by ants and dense plant 
occurrence by ant nests.  Harvester-ants move the seeds to their nests, remove the 
elaiosome (oily body) to feed to their larvae, and deposit the achene in the nutrient-rich 
waste area around the ant nest.  This nutrient-rich environment promotes germination and 
subsequent vigor of the milk thistle plants (Danin and Yom-Tov, 1990; Gabay et al., 
1994). 
Due to ease of seed germination and wind-spread seed dispersal, milk thistle is 
somewhat invasive in some parts of Europe, Australia, and the United States (Austin et 
al., 1988).  Invasiveness has been a problem in livestock production, as thick stands of 
thistle has the ability to exclude the animals from grazing and cutting off water access 
(Auld and Medd, 1987; Dingwall, 1950).  Control methods became necessary in these 
areas.  Control methods including pasture competition, grazing management, slashing, 
soil fertility management, chemical controls, and biological controls have been studied 
(Dodd, 1989; Sindel, 1991; Souissi et al., 2005; Zheljazkov et al., 2006) 
Cultivation 
Silybum is most commonly propagated through seed.  Milk thistle seeds require 
light to germinate, and germinate easily, although sporadically, with moisture.  
Germination studies have shown that seeds typically have a dormancy period after 
maturation lasting three to six months. (Singh et al., 1982)  The normal growing season is 
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from early spring to summer, with flower maturation occurring from June to July.  
There is nothing in the literature to indicate that S. marianum is photoperiodic.  Silybum 
can also behave as a biennial (Carrier et al., 2002).  Milk thistle is primarily produced in 
field cultivation and is generally regarded as having no major insect or disease problems 
(Andrzejewska et al., 2006). 
In cultivation for medicinal use, seed production and flavonolignan content is of 
great importance, as the seeds are commercially used for medicinal preparations.  As 
previously mentioned, a single milk thistle plant gives rise to numerous seed heads.  
Research performed in Argentina in 2002 described some of the trends governing seed 
production in milk thistle crops.  The number of seeds per plant is affected by the number 
of heads per plant.  The weight of the seeds per plant is the result of the number of heads 
per plant, the number of seeds per head, and the individual seed weight.  The number of 
seeds per head increases with bloom diameter and decreases with the number of heads 
per plant. (Gabucci et al., 2002) 
Pook (1983) examined the effect of shade on the growth of milk thistle in a 
greenhouse environment during winter.  Seedling growth and rate of growth are both 
negatively affected by increasing shade. However, increasing shade had minor effects on 
seedling morphology until irradiance was reduced to less than 0.20 r.l.i. (relative light 
intensity; 20% of full sunlight) at what point leaf expansion and relative growth rates 
declined rapidly.  Otherwise, seedlings demonstrated high tolerance to shading. 
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Other studies have shown that various agricultural conditions can affect the 
levels of bioactive compounds (silymarin) in milk thistle.  Hammouda et al. (1993) 
showed that silymarin levels and individual silymarin components were affected by water 
availability and nitrogen levels.  The highest silymarin level (63.1% silymarin in an ethyl 
acetate extract) was recorded in plants grown at 60% field capacity.  Levels of 
silychristin, silybin, and isosilybin were also highest at this water level.  Silydianin levels 
decreased with decreasing water availability.  Levels of silymarin in treatments of 75% 
and 40% field capacity were similar to levels found in wild plants (45.7%, 45.7%, and 
45.6% silymarin in an ethyl acetate extract, respectively).  Higher silymarin levels were 
observed in nitrogen levels of 100 and 150 kg/feddan (52.2% and 52.8% silymarin in an 
ethyl acetate extract; feddan = 1.038 acres). 
Warren (2003) also studied Silybum in a greenhouse environment under different 
nitrogen concentration.  Vegetative yields were affected under different nitrogen 
treatments of 47.1 mg/L, 100.6 mg/L, and 151.8 mg/L.  The lowest nitrogen treatment 
had significantly lower vegetative growth than the other two treatments.  Seed yield was 
also affected by nitrogen availability.  The highest nitrogen concentration yielded 104.7 
g/plant, while the lower two concentrations were not significantly different and had an 
average yield of 42.1 g/plant.  None of the nitrogen treatments significantly affected 
silymarin levels in the plants.  However, all compounds appeared to increase slightly with 
decreasing nitrogen concentrations. 
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Silymarin content can also affected by row spacing.  Seeds were sown in rows of 
two varying widths (25 and 50 cm between rows), and seedlings were thinned to two 
plants per hill 30 days after seeding.  Narrow row spacing of 25 cm increased the seed 
yield, but reduced oil and silymarin content compared to plants grown in rows 50 cm 
apart. (Omer et al., 1993) 
Silybum – Historical Uses 
While initially intimidating due to its spiny nature, Silybum has been historically 
used as a food crop.  Both the leaves and fruit are edible.  The leaves are particularly high 
in iron and, when despined, can be eaten in salads or steamed as greens.  Fruit can be 
toasted and served as a garnish for salad, rice, etc.  They can also be roasted and brewed 
as a coffee substitute (McKenna et al., 2002). 
 The use of milk thistle has been documented since the time of Greek philosopher, 
Theophrastus, (c.371-287 BCE) who referred to the plant by the name Pternix (Ball and 
Kowdley, 2005).  Pliny the Elder (23-79 AD) wrote that milk thistle was good for 
“carrying off bile,”(quoted in Flora et al., 1998).  Dioscorides (40-90 AD), author of de 
Materia Medica, described and wrote about milk thistle’s uses, saying a tea of the seeds 
could cure poisonous snake bites (Ball and Kowdley, 2005; Flora et al., 1998).  By the 
16th century, milk thistle was popularly used for hepatobilary diseases (Ball and 
Kowdley, 2005).  In 1652, prominent English herbalist, Nicholas Culpeper described 
milk thistle as an excellent aid “to open the obstructions of the liver and spleen, and 
thereby is good against the jaundice,” in his work “The English Physitian” (quoted in 
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Ball and Kowdley, 2005).  Milk thistle found its way to the Americas with early 
European colonists, and in the late 1800’s to early 1900’s the Eclectics, an American 
group of herbalist physicians, were using milk thistle for liver, spleen, kidney, and 
menstrual problems.  In the 1960’s milk thistle research gained new interest in Germany 
for the treatment for acute and chronic liver disease, as well as a hepatoprotective agent 
to protect against toxic liver injury. (Ball and Kowdley, 2005) 
Silybum - Modern Medicinal Use and Research 
 The compounds found in Silybum can act to prevent liver problems, as well as 
treat acute liver poisoning or disease.  Investigations have also been made into the use of 
milk thistle for treating cancer, controlling cholesterol, promoting nerve system health, 
and regulating blood sugar in those with type II diabetes.  Some of these studies use the 
complex, silymarin, while others use only silybin. 
The Liver 
 The main functions of the liver can be broken down into three categories, 
regulation, synthesis, and secretion of substances important to bodily homeostasis.  
Nutrients, such as glycogen, and vitamins and minerals are stored by the liver; 
furthermore, the liver purifies, transforms, and clears waste products, drugs, and toxins 
from the body.  The liver also possesses the capability to regenerate lost tissue, and can 
maintain its functions, despite moderate damage.  However, injury, disease, and ingestion 
of toxins can greatly reduce the liver’s ability to carry out its normal activities.  Chronic 
problems can occur from regular use of common substances like alcohol and 
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acetaminophen, and acute distress can occur from ingesting poisonous mushrooms.  Cell 
damage and impairment of the liver’s capacity are the source of most cases of liver 
dysfunction. (Earnest, 2005) 
 The literature suggests that the medicinal flavonolignans in Silybum work in four 
different ways to achieve beneficial effects in the liver.  First, they are antioxidants, anti-
inflammatory, and scavengers and regulators of intracellular glutathione content.  This 
quality helps explain other benefits outside of the liver.  Secondly, the flavonolignans can 
behave as cell membrane stabilizers and permeability regulators to prevent hepatotoxic 
chemicals from entering liver cells.  Thirdly, the compounds have the ability to promote 
RNA synthesis, helping to regenerate the liver.  Finally, these compounds can inhibit the 
transformation of stellate hepatocytes into myofibroblasts, which is the process that leads 
to cirrhosis. (Fraschini et al., 2002) 
 Several reviews have been written in recent years summarizing milk thistle’s use 
in the treatment of liver disease.  In 2002, Jacobs et al. wrote a systematic review and 
meta-analysis on milk thistle for the treatment of liver disease.  The group searched for 
and compared clinical studies done with milk thistle up until July 1999. (Jacobs et al., 
2002)  Two reviews were published in 2005 comparing clinical studies for milk 
thistle/silymarin for viral hepatitis and alcoholic liver disease (Ball and Kowdley, 2005).  
All of these reviews conclude that due to inconsistencies in dosages of milk thistle, 
source of the plant, and other experimental design flaws, no definitive statements can be 
made about the use or harm in using milk thistle for liver disease. 
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In another review, Rainone (2005) outlines some early studies conducted with 
milk thistle for liver disease that had positive, significant effects.  In a randomized, 
placebo-controlled study, researchers examined 106 patients with mild acute and 
subacute liver disease characterized by elevated serum transaminase levels.  At the end of 
the four week study, of the 97 patients who completed the study, there was a significant 
decrease in transaminase levels in the silymarin group. (Salmi and Sarna, 1982) 
Ferenci et al. (1989) performed a clinical trial examining the effects of a 
standardized milk thistle product (standardized to contain 70 to 80% silymarin) called 
Legalon, which is available in Germany and elsewhere in Europe, on cirrhosis.  In this 
study, 170 patients (46 with alcoholism) were randomized to receive Legalon or placebo 
for 24 to 41 months.  In the 146 patients who completed the study, a lower mortality rate 
was reported in the group who took Legalon.  The greatest benefit was found in those 
individuals whose cirrhosis was caused by alcoholism and in those whose cirrhosis was 
less severe on entry to the study.  
 In a 1989 double-blind study of 36 patients with chronic alcoholic liver disease, 
the patients who were given Legalon for six months showed normalization of bilirubin, 
aspartate transaminase and alanine transaminase serum levels.  The levels of these liver 
enzymes can be used as an indicator of liver health.  Patients receiving Legalon also 
showed an improvement in histology.  These effects were not observed in the placebo 
group. (Feher et al., 1989) 
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 In a 1998 study, 20 patients with chronic active hepatitis were randomized to 
receive silybin or placebo.  The milk thistle (silybin) group had significantly lower 
transaminase, bilirubin, and γ-glutamyltranspeptidase levels than the placebo group.  This 
study used silybin coupled with phosphatidylcholine, which appears to increase 
bioavailability. (Pares et al., 1998)  This coupling creates a “phytosome” form known as 
silipide or Siliphos® (Hoh et al., 2006; Kidd and Head, 2005).  The phosphatidylcholine 
is miscible in water and oil/lipid environments, increasing bioavailability.  (Kidd and 
Head, 2005)  This is synthesized by treating an acetone solution of silybin and 
phosphatidylcholine with n-hexane in a 1:1 molar ratio.  The precipitate is collected and 
dried under vacuum. (Ball and Kowdley, 2005) 
Cancer 
 The number of studies using silymarin, silybin, and other milk thistle preparations 
for various types of cancer has increased in recent years.  Prostate, colorectal, skin, and 
mammary cancers have been studied.  Effects of silymarin compounds on cancer-causing 
factors, like angiogenesis and reactive oxygen species (ROS), have also been studied.  
These effects have been studied in cell lines, animal, and human models. 
Silymarin and silybin were studied to determine their antiproliferative and 
apoptotic effects on rat prostate cancer cells.  Both compounds displayed antiproliferative 
and apoptotic effects, as well as a strong inhibition of DNA synthesis.  Both compounds 
worked in a time- and dosage-dependent manner with low toxicity.  The authors suggest 
that these compounds have the potential to be preventative and therapeutic against 
prostate cancer  (Tyagi et al., 2002)  Silymarin and silybin had cell cycle-inhibitory 
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effects in human prostate carcinoma PC3 cells.  In this study, silybin and silymarin (50-
100 µg/mL) inhibited cell proliferation, induced cell death, and cause G1 and G2-M cell 
cycle arrest in a time- and dosage-dependent manner. The authors suggested that silybin 
was the major active compound, but other stereoisomers (isosilybin A & B, silydianin, 
silychristin, and isosilychristin) in the silymarin mixture contribute to its efficacy. (Deep 
et al., 2006) 
 Angiogenesis is known to be associated with tumor growth in the body.  Yang et 
al. (2003) studied the anti-angiogenic effect of silymarin and silybin compared to the 
drug thalidomide in LoVo colon cancer cells.  They found that silymarin and silybin 
exhibited a comparable, if not better, effect on anti-angiogenesis in the colon cancer cells.  
The authors go so far as to suggest silymarin/silybin as an anti-cancer treatment, 
especially when considering the extremely low toxicity of silymarin and silybin.  In a 
2006 pilot study, oral silybin (in the form of silipide) was given to patients with 
confirmed colorectal adenocarcinoma at rates of 360, 720, or 1,440 mg silybin daily for 7 
days.  The authors identified several silybin metabolites and conjugates in plasma and 
tissue of the patients at levels similar to known pharmacologic activity levels.  While the 
levels used in this study did not affect apoptosis and antioxidant markers in the blood, the 
treatments were determined as safe and deserving of further study as a human colorectal 
cancer chemopreventative agent. (Hoh et al., 2006) 
 Silymarin and its components have been shown effective against UV damage and 
skin cancer.  Silybin was evaluated for effect on UV irradiation-induced apoptosis in 
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human malignant melanoma cells (A375-S2 cells) by Li et al.  Cells were treated with 
500 µM silybin for 12 hours.  This significantly inhibited UV irradiation-induced 
apoptosis in the cells. (Li et al., 2004)  In a 2007 study, skin epidermal cell line HaCaT 
was used to study UVA-induced damage.  UVA-induced oxidative stress was reduced in 
a concentration-dependent manner with silymarin concentrations ranging from (0.7-34 
mg/L).  Silymarin reduced the generation of reactive oxygen species with lead to 
inflammation, immunosuppression, photoaging, and photocarcinogenesis.  UVA-induced 
DNA single strand breaks and caspase-3 activity were also significantly decreased by 
silymarin. (Svobodova et al., 2007) 
 Silymarin has also shown significant anti-inflammatory effects in liver tissue, 
exhibiting a number of effects.  These include inhibition of neutrophil migration and 
Kupffer cells, as well as marked inhibition of leukotriene synthesis and formation of 
prostaglandins.  While no molecular basis for silymarin’s activity has been established, it 
is hypothesized that it might be related to the inhibition of transcription factor NF-κB.  
This transcription factor regulates the expression of genes involved in the inflammatory 
process, cytoprotection, and carcinogenesis. (Fraschini et al., 2002; Polyak et al., 2007)   
Neural Effects 
 The efficacy of flavonolignans from milk thistle on neurons in culture has also 
been studied, suggesting potential benefits these compounds have on the nervous system.  
Kittur et al. found that milk thistle seed extract promoted neuronal differentiation, 
enhanced nerve grown factor-induced neurite outgrowth and promoted neuron survival in 
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PC-12 (pheochromocytoma) cells.  Milk thistle extract also prevented oxidative stress-
induced cell death in cultured rat primary hippocampal neurons. (Kittur et al., 2002) 
 The effects of silymarin on brain amines and metabolites were studied using 
BALB/c mice.  Mice were treated intraperitoneally (into the abdominal cavity lining) 
with 0, 10, 50, or 250 mg/kg of silymarin for 5 days.  Serotonin levels in the cortex and 
dopamine and norepinephrine levels in the cortex were increased in the highest treatment 
group.  This indicates that silymarin may have slight serotonergic, dopaminergic, and 
noradrenergic effects. (Osuchowski et al., 2004) 
Type II Diabetes 
 Silymarin is effective in the treatment of type II diabetes.  Oxidative stress can 
either cause pancreatic β-cell damage and metabolic abnormalities that can cause or 
aggravate diabetes.  A 4-month randomized, double-blind clinical trial was performed in 
51 patients with type II diabetes.  One group received a 200 mg silymarin tablet 3 times a 
day plus conventional therapy. The other group received a placebo tablet and the same 
conventional therapy.  After 4 months, levels of glycosylated hemoglobin, fasting blood 
glucose, total cholesterol, low density lipoprotein, triglyceride, SGOT, and SGPT were 
significantly lowered in the silymarin group.  A slight, but not significant, decrease in 
weight, systolic and diastolic blood pressure was found in the silymarin group.  The 
authors concluded that silymarin does have beneficial effects on the glycemic profile in 
individuals with type II diabetes. (Huseini et al., 2006)  These results correlate with 
earlier studies performed on silymarin as a hypocholesterolaemic drug, its effect on 
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cholesterol absorption in rats, and effect on oxidative stress in hypertriglyceridemic rats 
(Skottova et al., 2004; Skottova and Krecman, 1998; Sobolova et al., 2006) 
Veterinary Applications 
 Some research has been done using milk thistle in veterinary applications.  In a 
review of pharmacologic therapies for hepatobilary diseases in dogs and cats, the author 
mentions milk thistle as a hepatoprotector with little to no side effects or 
contraindications (Sartor and Trepanier, 2003).  In a 2004 study, a silymarin-
phospholipid complex was shown effective in reducing toxicity of aflatoxin B1 in broiler 
chickens.  Aflatoxin B1 is a mycotoxin commonly associated with animal feed, especially 
feeds made with peanuts and cereals. (Tedesco et al., 2004a)  Silymarin has also been 
beneficial in dairy cows during peripartum, a time where the cows are subject to fatty 
liver (Tedesco et al., 2004b).  Furthermore, milk thistle silage lowered triglycerides and 
liver enzymes in cows, and the silage positively influenced the enzymatic activity of 
blood serum in the transition period after calving (Grabowicz et al., 2004).  
Silybum – Chemistry & Biosynthesis 
 The major class of biologically active compounds found in Silybum is known as 
flavonolignans.  The group of flavonolignans in Silybum that exhibit hepatoprotective 
properties is known as silymarin.  Silymarin was originally thought to be one large, 
complex molecule.  However, in 1974, it was found that silymarin is actually a mixture of 
several flavonolignans. (Wagner, 1974)  Flavonolignans are formed through the free-
radical oxidative coupling of the flavonoid dihydroquercetin (also called taxifolin) and 
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coniferyl alcohol (a component of lignan) (Kim et al., 2003; Kurkin, 2003)  This 
reaction forms silybin, thought to be the most bioactive component of silymarin, and a 
mixture of regioisomers and diastereomers (stereoisomers that are not mirror images of 
one another) (Kurkin, 2003).  The three main flavonolignans in Silybum are silybin (also 
referred to as silybinin), silychristin and silydianin.  Diastereomers of silybin (silybin A 
and B) have been isolated, as well as the regioisomer of silybin, isosilybin A and B via 
X-ray crystallographic analysis and optical rotation data coupled with 1C and 13H NMR 
spectral data (Lee and Liu, 2003). (Figure A-1)    Kurkin et al. (2001) achieved the 
identification of 2,3-dehydrosilybin with the use of UV and 1H-NMR spectroscopies 
(Kurkin et al., 2001).  Most recently, a diastereomer of silychristin (now known as 
silychristin A) was discovered and referred to as silychristin B (Martin et al., 2006).  
Other minor compounds include dehydrosilybin, desoxysilychristin, desoxysilydianin, 
silybinome, isosilychristin, silymonin, silandrin, silyhermin, and neosilyhermins A and B. 
 In addition to the flavonolignans, there are many other compounds of interest in 
Silybum.  Most recently, two pentacyclic triterpenes were elucidated named silymin A 
and B (Ahmed et al., 2007).   
Silybum - Extraction 
 In order to obtain silymarin from milk thistle, the desired compounds must be 
extracted from the seeds.  The extraction of desired compounds from a solid matrix, such 
as plant material, can be thought of as a five step process, and each step of the process 
requires careful control for optimization of the overall extraction.  These steps include the 
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desorption of the compound(s) from the active sites of the matrix, diffusion of the 
compound(s) into the matrix itself, solubilization of the analyte in the extractant, 
diffusion of the compound in the extractant, and collection of the extracted solutes. 
(Camel, 2001; Pawliszyn, 1993)  Traditionally, compounds have been extracted using 
Soxhlet extraction, sonication, and blending; however, these methods normally require 
long extraction times, high solvent use, and low temperatures.  Furthermore, these 
methods often require subsequent clean-up, concentration, and perhaps filtration of the 
desired compounds before analysis.  These steps introduce a high probability of loss 
and/or contamination of the sample.  There are several technologies that have emerged in 
the past decade that reduce these problems and ease the optimization of the extraction 
process.  These technologies include supercritical fluid extraction, pressurized liquid 
extraction, and microwave-assisted extraction. (Camel, 2001)  All of these methods have 
potential for use in milk thistle extraction for analysis. 
Current Methodologies 
There are many studies that explore the possible methods for silymarin extraction, 
and there are several considerations when preparing these extractions.  Silymarin 
compounds are most highly concentrated in the seeds of milk thistle, and are 
hydrophobic.  For the most effective silymarin recovery, the seeds should be defatted 
prior to extraction.  Furthermore, the polarities of the silymarin compounds have a wide 
range, with taxifolin being highly polar, to silybin A & B which are only slightly polar. 
(Barreto et al., 2003)  The solvents, temperatures, and time durations of the extractions all 
have to be adjusted accordingly to achieve the most efficient and complete extract. 
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Pharmacopoeias call for long extractions using a Soxhlet apparatus.  This can be 
adapted using series of sonication, vortexing, and centrifugation to achieve complete 
extracts.  Still, other new technologies have been developed that can maximize the 
extraction process. 
Supercritical Fluid Extraction 
 In supercritical fluid extraction (SFE) the extractant (or solvent) is in its 
supercritical state, where both temperature and pressure are beyond the critical state of 
the solvent.  This gives the solvent unique properties of both liquid and gas in that the 
viscosity is lower than that of liquid and the diffusion coefficients are higher.  This allows 
for more efficient extractions.  Polarity of the compounds to be extracted is of primary 
consideration. (Camel 2001)  Pure carbon dioxide (CO2) is the most commonly used 
solvent in SFE because of its low critical constants, it is non-toxic, non-flammable, and is 
available in high purity at low cost. (Feher et al., 1989)  CO2 efficiently extracts non-
polar to low polarity compounds; however, the addition of a modifier solvent to the CO2 
is required for effective extraction of mid to highly polar and ionic compounds. (Camel, 
2001) 
 Methanol is commonly used as a modifier in supercritical extraction because if its 
miscibility with CO2, and methanol is thought to have the ability to disrupt the bonding 
between solutes and plant matrices at high percentages; however, ethanol is also an 
attractive modifier as it is less toxic than methanol (Lang and Wai, 2001).  Several 
studies have been done with the use of ethanol as a modifier.  Catchpole et al. (2002) 
studied different solvent mixtures for supercritical extractions for four popular herbs, saw 
  
 
29
palmetto, St. John’s wort, kava root, and Echinacea purpurea.  While adding ethanol to 
the CO2 did increase the yield of compounds from some plants, it also increased 
undesirable compounds into the extract, like some color components and high molecular 
weight waxes.  The supercritical extraction also did not retrieve all the desired chemicals 
out of the plant matrices, even with the addition of ethanol to the solvent.  For example, 
when Echinacea was extracted using both CO2 only and CO2 + ethanol, high levels of 
alkamides were extracted, but no chicoric acid or polyphenolics were obtained in the 
extract.  
Pressurized Liquid Extraction 
 Pressurized liquid extraction (PLE) is a new technique that has been developed 
over the past 10 years.  This form of extraction appears under several different names 
including accelerated solvent extraction (ASE™, a Dionex trade mark), pressurized fluid 
extraction (PFE), pressurized solvent extraction (PSE), or enhanced solvent extraction 
(ESE).  In this form of extraction, temperature and pressure are elevated, placing the 
solvent in a subcritical state, which provides greater mass transfer properties.  Elevated 
temperature (usually between 100-200 C) allows for a decrease in solvent viscosity, thus 
disrupting the solute-matrix interactions and increasing diffusion coefficients more 
efficiently.  Furthermore, elevated temperatures cause a change in the distribution 
coefficients of the desired compounds which allows for greater solubilization into the 
solvent.  Under these conditions, a complete extract from a sample can typically be 
obtained in 5-10 minutes. (Camel, 2001) 
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 Benthin et al. (1999) investigated the extraction efficiency of pressurized liquid 
extraction (PLE) of five various medicinal plant species compared to Pharmacopoeia 
monographs (which serve as official standards for the quality control of many medicinal 
plants).  PLE works on the principle of static extraction with superheated liquids.  The 
Pharmacopoeia guidelines for milk thistle analysis include a 4 hour Soxhlet extraction in 
petrol for defatting, with a subsequent 5 hour Soxhlet extraction with methanol to extract 
the flavonolignans.  These extracts were compared to PLE extracts which were obtained 
in a single extraction cycle using a 5 minute extraction in hexane at 100 C for seed 
defatting, followed by a 5 minute extraction in methanol at 100 C.  For the extraction of 
milk thistle, the group found that the PLE extract yielded slightly higher amount of 
flavonolignans in far less time and with five times less solvent consumption than the 
Pharmacopoeia guidelines.  Overall, the group found that PLE extractions saved a 
significant amount of time and solvents for extractions and extracted equal or greater 
amounts of the medicinal compounds. 
  Another exciting possibility for PLE extraction is the option to use hot water as a 
solvent.  Water is useful in extracting polar compounds, but has the unique capability of 
extracting plant material without the necessity of prior defatting.  When water is heated 
up to its subcritical temperature, there is a decrease in the dielectric constant, or 
permittivity.  Therefore, water at 250 C has a dielectric constant of 27, which is similar to 
that of methanol (33) and ethanol (24), which gives water, at this temperature, solubility 
characteristics of these two organic solvents. (Barreto et al., 2003)  The temperature of 
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water in a PLE cell can be increased over a period of time, and based on the polarities of 
the desired compounds in a sample, various compounds will be pulled out of the plant 
matrix as the temperature increases.  For example, Barreto et al. (2003) demonstrated that 
the more polar compounds in a milk thistle seed sample (taxifolin and silychristin) could 
be pulled out in a hot water extraction at 85 C and the less polar compounds (silybin A 
and B) were extracted at 100 C.  Furthermore, they saw an increase in the yield of more 
polar compounds in the hot water extraction over the traditional Soxhlet extraction in 
ethanol.  Finally, the hot water method is also advantageous in that since the solvent used 
is water, there is no required, further clean-up of the extract. 
Microwave-assisted Extraction 
 Microwave-assisted extraction (MAE) is another fairly new, effective extraction 
method.  Microwave radiation is used to heat a solvent-sample mixture.  Microwave 
energy is non-ionizing and causes molecular motion by migration of ions and rotation of 
dipoles.  Dipole rotation refers to the alignment of molecules that have dipole moments 
(either permanent or induced) in both the solvent and the sample, due to the electric field.  
As microwaves are applied to an extraction cell, the molecules go through a cycle of 
thermal disorder followed by a re-alignment.  This results in rapid heating.  This heating 
is instantaneous and occurs in the heart of the sample which results in rapid extraction 
times.  Typically, a solvent is chosen that absorbs microwaves, which allows for heating 
of both the sample and solvent; however, for thermolabile compounds, a non-absorbing 
solvent can be used which allows the release of compounds into a cold solvent.  
Microwave radiation has shown so far to have no degrading effects on extracted 
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compounds, unless the temperature in the extraction cell exceeds the temperature ranges 
for the compounds. (Camel 2001)  Several studies have been done to determine the 
effectiveness of MAE on material from various plants, and they have proven that extracts 
can be generated in as little at one minute, depending on the plant and solvent used (Huie, 
2002). 
Silybum analysis 
 Many advances have been made in screening techniques for medicinal plant 
extracts in the past twenty years.  Many of the most effective techniques include the use 
of high performance liquid chromatography (HPLC) coupled with a detector that has 
some capacity for the determination of chemical structure of the components separated by 
LC.  The benefits arising from the use of LC in these applications is that LC is generally 
rapid and does not lead to decomposition, material loss, or artifact formation.  Some of 
the most recent advances in this area are the coupling of HPLC with UV diode array 
detection (LC/UV), mass spectrophotometry (LC/MS), or nuclear magnetic resonance 
(LC/NMR).  Each of these methods has benefits from the perspective of structure 
elucidation and/or identification. (Hostettmann and Marston, 2002) 
 Minakhmetov et al. (2001) achieved the complete separation, identification, and 
quantification of the main flavonolignan constituents from milk thistle seeds.  They 
discovered the optimum parameters for milk thistle analysis via HPLC.  Their mobile 
phase was a mixture of acetonitrile and water (27:73 volume %, pH 3.0).  Ethanoic acid 
was added to the water to reach the desired pH.  Through this analysis they were able to 
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resolve and identify silybin, silydianin, silychristin, and taxifolin.  While a standard of 
2,3-dehydrosilybin was used in this study, it was not found as an eluent.  
 Further studies have employed LC coupled with mass spectrophotometry to 
analyze milk thistle samples.  Bilia et al. (2001 and 2002) published studies using LC/MS 
for the analysis of calendula, milk thistle, and passion flower.  The HPLC method used 
was very similar to the parameters found by Minakhmetov et al. (2001).  Since MS was 
used as a detector, the water in the mobile phase was adjusted to a pH of 3.0 using formic 
acid. (Bilia et al., 2002; Bilia et al., 2001) 
 Capillary electrophoresis (CE) is another analytical method that can be utilized 
for silymarin analysis.  Kvasnicka et al. (2003) compared the analysis of milk thistle via 
HPLC to that of CE.  They concluded that each method gave comparable results; 
however CE did provide for shorter analysis and better resolution of silydianin and 
silychristin over the HPLC, which HPLC allowed for the separation of the diastereomers, 
isosilybin A and B.  Warren (2003) used CE to analyze milk thistle from hydroponic 
experiments to determine the effect of nitrogen levels on flavonolignans.  Taxifolin, 
silybin, and silydianin were identified in these experiments. 
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III. Preliminary Study, Germination Tests, and Sterilization Procedure 
Abstract 
 A preliminary experiment was conducted to look at the effect of leaf harvests on 
growth, development, and flavonolignan content in milk thistle seeds.  Plants grew from 
seedling to maturity in approximately four months in a greenhouse environment.  The 
flavonoid taxifolin, which is a component of silymarin and a precursor to flavonolignans, 
was significantly decreased by the harvesting treatments. 
 Due to the weedy nature of Silybum marianum, there were some unforeseen 
obstacles in germinating enough plants to conduct the proposed experiments.  
Germination was sporadic, and fungal seed contamination decreased seedling viability.  
Germination and sterilization trials were then pursued to determine the most efficient way 
to produce viable seedlings for experimentation.  Seed germination trials were done in a 
growth chamber using Petri dishes with germination paper. Organically grown seeds 
from Johnny’s Select Seeds were imbibed overnight and either placed in the chamber or 
pre-chilled for one week.  Both groups succumbed to fungal infections before 
germination data could be collected.  Germination trials were also performed with seven 
other seed sources including seeds from Frontier Natural Products Co-op (organic and 
non-organic seeds), Wild Weeds (two seed lots, one from Oregon and one from Croatia), 
Stony Mountain Botanicals, Ltd., and Richters Herbs.  The seeds harvested from Croatia 
showed the best germination and were used for all subsequent experiments.  Also, a 
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sterilization procedure using 70% ethanol and a 5% bleach/ 1% SDS solution was 
chosen to sterilize seeds before Silybum seeds were sown for experimental use.    
Introduction 
Preliminary work included growing and harvesting plants in small containers, 
performing germination tests on various seed sources, and determining a seed 
sterilization technique.  The experiment growing plants in small containers occurred first 
with seeds from Johnny’s Select Seeds.  These germinated rapidly, and a small 
preliminary study was done by growing these seedlings in four inch trays.  Ten plants 
were chosen to have a basal leaf between leaf stages 3-5 removed.  Twenty plants were 
chosen to have a cauline leaf removed once the flower stem had elongated.  Seed was 
harvested off of these plants.  Seed was also harvested from twenty-four additional plants 
that had not had any leaves removed.  Growth parameters of stem height and days to 
maturity were observed.  The harvested seed from all the plants was analyzed for 
flavonolignan content. 
When subsequent germination attempts were unsuccessful, germination trials 
were started.  Organically grown seeds from Johnny’s Select Seeds were used in 
germination trials in a small growth chamber.  Seeds were germinated in Petri dishes with 
germination paper.  Seeds were imbibed overnight and either put straight into the growth 
chamber or pre-chilled at 4 C for one week.  These seeds were heavily contaminated with 
fungi, affecting germination and seedling viability.  With this discovery, a reliable 
sterilization technique was sought out.  The sterilization procedure used for all 
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subsequent experiments consisted of an ethanol wash followed by a bleach/SDS 
solution.  Further germination trials were performed using seven other seed sources 
including seeds from Frontier Natural Products Co-op (organic and non-organic seeds), 
Wild Weeds (two seed lots, one from Oregon and one from Croatia), Stony Mountain 
Botanicals, Ltd., and Richters Herbs.  After all of these initial questions were addressed 
and answered, further progress could be made on experiments addressing environmental 
stress. 
Materials & Methods 
Preliminary Study 
 Seeds from Johnny’s Select (Winslow, ME) were sown into a flat in the 
greenhouse.  After germination, the seeds were transplanted into four inch polystyrene 
Speedling (Speedling, Inc., Sun City, FL) trays in Berger BM1 growth media (Berger 
Peat Moss, Quebec, Canada) and grown to maturity. (Figure A-2)  A one hundred mg/L 
solution of 20-9-17 (N-P-K) fertilizer was applied once a week starting three weeks after 
transplanting.  Plants were chosen at random to undergo two leaf harvests.  One harvest 
was performed on ten plants during the basal growth period (treatment 1).  In this harvest, 
one small, healthy leaf between true leaf stages 3-5 was removed.  The second leaf 
harvest of cauline leaves was performed on another twenty randomly chosen plants 
(treatment 2).  One leaf off of the flowering stem was chosen.  One plant did appear in 
both random leaf harvest selections.  As the flowers matured, cloth, drawstring bags (10 x 
15 cm; Consolidated Plastics Co., Inc., Twinsburg, OH) were placed over the seed heads 
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to prevent loss of seeds, as the seed heads open at maturity and seeds are dispersed via 
wind with the pappus attached to each seed.  Mature seeds were harvested from all the 
plants that had experienced a leaf harvest.  An additional random selection of twenty-five 
plants that had experienced no leaf harvesting was chosen for seed harvest (treatment 3).  
The seeds were harvested off the remainder of the plants and bulked.  At the time of seed 
harvest, growth data was recorded, including stem height, mature seed weight and 
number, immature seed weight and number, and days to maturity.  Seeds were stored at 4 
C until analysis.  Growth and yield parameters were analyzed using mixed model 
ANOVA and LSD means separation, on a complete random design (CRD) using SAS 
(SAS Institute, Inc., Cary, NC). 
For analysis, seeds were sterilized using 70% ethanol followed by a 5% 
bleach/1% sodium dodecyl sulfate (SDS) solution. (Procedure D-1)  The seeds were 
allowed to dry and then were ground with a coffee mill.  For flavonolignan extraction, 
100 mg Silybum seed meal was sonicated with petroleum ether for 30 min for defatting.  
This was followed by a triple extraction with methanol.  After each methanol addition, 
the samples were sonicated for 20 min.  The aliquots from each methanol extraction were 
pooled and evaporated to dryness under a nitrogen stream.  Samples were then 
redissolved in 1.0 mL of methanol and 100 µL of 1.0 mg/mL hesperetin internal standard 
was added.  This mixture was filtered through a 0.45 µm syringe filter into 2 ml crimp-
top HPLC sample vials. (Procedure D-2)  Extracts were analyzed for flavonolignan 
content with an Agilent 1100 HPLC (Agilent Technologies, Santa Clara, CA) equipped 
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with a diode array detector (DAD), and a Luna C-18(2) (250 x 4.6 mm, 5 µm) column 
(Phenomenex, Torrance, CA) using a method adapted from Wallace et al. (2003).  The 
column was held at 40 C.  The injection volume was 25 µL.  Mobile phase A consisted of 
a 20:80 methanol: water solution, and mobile phase B consisted of an 80:20 methanol: 
water solution.  The solvent gradient started with an 85:15 mixture of mobile phases A 
and B for 5 min.  Over the next 15 min, the gradient changed linearly to 45:55 (solvent A: 
solvent B) and was held constant for 15 min.  The ratio then changed linearly to 0:100 
(solvent A: solvent B) over 3 min.  This was held constant for 5 min.  The gradient then 
changed linearly over 1 min to the original ratio of 85:15 (solvent A: solvent B) for a 
total run time of 44 min. (Table B-1)  The flow rate for the gradient program was held 
constant at 0.8 mL/min. (Procedure D-3)  Flavonolignan quantities are reported in mg of 
compound per g of seed (mg/g). (Procedure D-4)  Mixed model ANOVA with LSD 
means separation, using a complete random design (CRD) with sampling, was performed 
using SAS to analyze flavonolignan content (SAS Institute, Inc., Cary, NC). 
Initial Germination Study 
 Seed germination was studied due to poor germination that occurred after the 
preliminary experiment.  Organically grown Silybum marianum seeds were obtained 
from Johnny’s Select Seeds.  Initial attempts at germinating seeds for subsequent studies 
were unsuccessful and inconsistent with the germination rate reported by the seed 
company.  Therefore, germination techniques were studied.   
A small growth chamber (Model E-30B; Percival Scientific, Perry, IA) was 
programmed for 16 hours of dark at 20 C and 8 hours of light (photosynthetic photon flux 
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of 300 µmol m-2 s-1) at 26 C.  Five Petri dishes were prepared containing moistened 
germination paper and twenty seeds per plate.  The dishes were placed in the growth 
chamber with the lid askew as to prevent evaporation of the water and overheating of the 
seeds.  Another five groups of twenty seeds were subjected to a pre-chilling method as 
described by the Seed Lab Manager at Johnny’s Select Seeds (Norma Rossel, personal 
communication).  These plates were prepared as previously described with the addition of 
a one week pre-chilling period at 4 C. 
 A similar trial was performed on various seed sources to determine which seed 
source was the most reliable to use for the environmental stress experiments.  Seven seed 
sources were obtained including the following:  Johnny’s Select Seeds, Frontier Natural 
Products Co-op (Norway, IA), Frontier Natural Products Co-op (organically grown), 
Wild Weeds (Blue Lake, CA) (grown in Oregon), Wild Weeds (grown in Croatia), Stony 
Mountain Botanicals Ltd. (Loudonville, OH), and Richters Herbs (Ontario, Canada).   
Surface Sterilization Technique 
 Sterilization was deemed necessary after viewing the results from controlled 
germination.  Seeds were subjected to a treatment with 5% bleach for five min washed 
off with water three times.  The seeds were then grown on Petri dishes in the manner 
previously described, again comparing a pre-chilled group to a group placed directly in 
the growth chamber.  When fungal growth was still prevalent, a more aggressive 
sterilization procedure was sought.  The method used for the remainder of the studies 
involved washing the seeds for two minutes in a 70% ethanol mixture, rinsing the seeds, 
placing them in a 5% bleach/95%water/1% sodium dodecyl sulfate (SDS) solution for 
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fifteen minutes, and thoroughly rinsing the seeds with water. (Procedure D-1)  This 
method was used for seeds prior to germination, as well as harvested seeds from 
subsequent experiments previous to grinding and analysis. 
Results 
Preliminary Study 
 Average stem height, number and weight of mature seeds per plant, and total 
number and weight of seeds per plant were significantly affected by leaf harvest 
treatments. (Table B-2)  Average stem heights were 26.0 cm, 25.0 cm, and 32.6 cm for 
the basal leaf removal, the cauline leaf removal, and no leaves removed, respectively.  
The height of plants with no leaves removed varied significantly from the other two 
treatments (P<0.05). (Table A-3)  Similarly, the number of mature seeds harvested from 
plants that had had no leaves removed was significantly greater than the two treatments 
where leaves were removed (P<0.05).  Seeds counts for treatments 1, 2, and 3 were 16, 
13, and 22 seeds/plant, respectively. (Table A-4)  The weight of mature seeds for 
treatments 1, 2, and 3 were 0.399, 0.319, and 0.621 g/plant, respectively, with the weight 
of treatment 3 varying significantly (P<0.05).  Total seed weights were 0.432, 0.340, and 
0.654 g/plant, respectively. (Table A-5)  Again, the plants that had no leaves removed 
were significantly different than the other two treatments (P<0.05). 
Mixed model ANOVA analysis showed that only the levels of taxifolin were 
significantly affected by the leaf removal treatments. All other flavonolignans were not 
significantly affected by treatments. (Table B-3)  The seed-only treatment contained 1.43 
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mg taxifolin/g of seed meal, while the leaf removal treatments yielded an average of 
0.97 mg/g taxifolin.  While the flavonolignans were not overall affected by the treatment, 
LSD means separation did find some significance between certain treatments.  
Silychristin levels indicated a difference between seed-only harvest and basal leaf harvest 
(P<0.05), with average concentrations of 4.48 and 3.32 mg/g, respectively. (Figure A-6)  
Total silymarin concentrations also showed differences between seed only harvest and 
basal leaf harvest, with average silymarin concentrations of 30.73 and 25.19 mg/g, 
respectively. (FigureA-7 and Table B-3) 
Unknown compounds 3, 4, and 7 were also significantly affected at P<0.05. 
(Table B-4)  For unknown 3, cauline leaf and seed only harvests were significantly 
greater than the basal leaf harvest.  The concentration of unknown 4 was highest in the 
seed-only harvest and lowest in the cauline leaf harvest.  Unknown 7 concentrations were 
highest in the cauline leaf harvest treatment and lowest in the basal leaf and seed-only 
harvests. (Figure A-8 and Table B-4) 
Initial Germination Study 
 Seeds that were placed in the growth chamber with no pre-chilling treatment 
started to show signs of fungal infection within four days placement into the growth 
chamber.  The fungi appeared to be most concentrated around the area of radicle 
emergence from the seed.  When seeds subjected to the pre-chilling treatment were 
observed, fungal growth was already apparent, despite the cold conditions.  Both groups 
showed germination.  However, the prevalence of the fungal growth overtook the radicle 
in many cases.  Germination could not be considered successful in most cases.   
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The germination trials performed with the seven seed sources determined that 
the Wild Weeds (Croatia) source demonstrated the highest level of germination and 
dependability.  These seeds were used for all the subsequent environmental stress 
experiments. 
Discussion 
Preliminary Study 
 The growth and yield data from this study suggested that the removal of 
vegetative growth from milk thistle has significant effects on total plant growth and seed 
development.  Possibly, these results are exaggerated in this study because of the 
confined growing space these plants were subjected to.  From observation, these plants 
did not produce the amount of foliage that is typical for this plant when grown in the field 
or large, hydroponic bags in the greenhouse.  Therefore, the removal of any vegetative 
growth limited the plants accumulation of photoassimilates, limiting the available 
resources for further growth and secondary metabolite production. 
 While there was no difference in the production of individual silymarin 
components among the treatments, the total amount of silymarin produced was 
significantly higher in the plants with no leaves removed than the plants that had a basal 
leaf removed.  This suggested that early removal of vegetative material significantly 
affected that amount of flavonolignans that were yielded at seed maturity.   
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Initial Germination Study 
 Milk thistle is a weedy species, and one successful trait that many weeds possess 
is sporadic germination.  This allows for stronger success for a wild population to 
reproduce to the next generation, as the entire seed bank is not destroyed by one 
devastating event, such as a severe drought. (Dodd, 1989; Groves and Kaye, 1989)  Milk 
thistle is also known to germinate at a much lower rate soon after the seeds reach 
maturity.  After a “curing” period of usually 3-6 months, germination improves.  Actual 
age of the seeds from various sources was unknown, therefore, the possibility remains 
that the seeds had not yet reached their maximum potential for germination. 
 Furthermore, the seeds from Johnny’s Select that were used in the initial leaf 
harvest study had been in cool storage since 2001, so it stands to reason that these seeds 
were indeed more prepared to germinate than newer seeds also obtained from Johnny’s 
Select as well as other seed sources. 
Initial germination studies were riddled with fungal problems and poor 
germination.  Surface sterilization was a partial cure for the fungal problem.  However, 
seeds still did not germinate when given recommended light and moisture 
recommendations.  The probability exists that these seeds were still not physiologically 
mature enough to achieve high germination rates or the fungi had weakened seed 
viability. 
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IV. Flavonolignan Content of Various Seed Sources 
Abstract 
 Flavonolignan in milk thistle have been shown to vary depending on the climate 
in which the plants were grown and genetic diversity within a population.  This study 
looked at the silymarin levels in seeds from eight seed sources from around the world.  
Tested seeds were grown in Oregon, Croatia, Serbia, and various parts of the midwest 
United States and Europe.  All flavonolignans were significantly different in each seed 
source.  Total silymarin concentrations ranged from 56.9 mg/g of seed meal in seeds from 
Stony Mountain Botanicals to 29.6 mg/g of seed meal in seeds from Johnny’s Selected 
Seeds.   
Introduction 
The levels of flavonolignans in Silybum have been shown to differ when plants 
are grown in varying climates (Kurkin, 2003).  Seeds were obtained from eight different 
seed sources around the world.  Geographic areas covered include the midwest United 
States, Oregon, Croatia, Serbia, and Europe.  Samples from each of the seed sources were 
extracted and analyzed by HPLC to observe the differences in silymarin profiles from 
each geographic area. 
Materials & Methods 
Seeds were obtained from Frontier Natural Products Co-op (organically and non-
organically grown lots), Johnny’s Select Seeds, Wild Weeds (seeds lots grown in Croatia 
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and Oregon), University of Belgrade, Stony Mountain Botanicals, Ltd., and Richters 
Herbs.  Seeds were sterilized, ground to 20 mesh, extracted once with petroleum ether for 
defatting, and extracted in triplicate with methanol for flavonolignan analysis. 
(Procedures D-1 – D-4)  Analysis was performed on an Agilent 1100 HPLC equipped 
with a DAD detector as detailed in Chapter III.  Flavonolignan levels were statistically 
analyzed in a CRD using mixed model ANOVA and Tukey means separation. 
Results 
 All silymarin components and unknown compounds were significantly affected 
by the seed source. (Table B-5 and B-6)  Tukey means separation did show differences in 
compounds between seed sources. (Figure A-9)  Seeds obtained from Stony Mountain 
Botanicals, Ltd. (SM) and Frontier Natural Products Co-op (F) yielded the highest total 
silymarin concentration at 56.90 and 51.41 mg/g of seed meal, respectively.  The lowest 
concentration of 29.6 mg/g silymarin was found in the seeds from Johnny’s Select Seeds. 
(Figure A-11)  Varying seed sources also had different flavonolignan profiles. (Figure A-
10)  The silymarin profiles of SM and F seeds also had the highest concentrations of 
silybin A & B.   
Discussion 
 This analysis confirms the great variability in flavonolignan content that exists in 
milk thistle plants.  Kurkin (2003) speaks of milk thistle grown in Yugoslavia, Bulgaria, 
various parts of Russia, Hungary, and Sweden varying in the ratios of individual 
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flavonolignans in the silymarin complex.  Seeds from plants grown in Russia had a 3:1 
ratio of silybin to silydianin.  Seeds harvested in Yugoslavia had 10:4:1 ratio of silybin to 
silydianin to silychristin.  Silydianin was the primary compound in seeds grown in 
Ukraine.  Plants from Sweden also had higher concentrations of silydianin than silybin. 
In this seed source analysis, the SM and F seed sources contained the highest total 
silymarin content as well as the highest content of silybin A & B.  Silybin is commonly 
regarded as the most bioactive constituent of silymarin (Crocenzi and Roma, 2006).  
However, silydianin was present in the highest concentrations across all seed sources 
analyzed here.  Some of the sources, like Frontier Natural Products Co-op, sell milk 
thistle seeds for dietary supplementation, not necessarily for reproduction of the plant.  
This reiterates the importance in quality control in herbs when growing plants for 
medicinal extracts.   
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V. Population Density Effects on Growth, Yield, and Flavonolignan 
Production 
Abstract 
Milk thistle, Silybum marianum (L.) Gaertn., is grown throughout the world for its 
hepatoprotectant flavonolignans, known collectively as silymarin.  Silymarin is found 
primarily in the seeds.  Milk thistle was grown in a controlled environment (16 hours of 
light at 1200 µmol/m2/s and 23 C and 8 hours of dark at 16 C) for determination of plant 
growth, seed yield, and flavonolignan content under various levels of population density 
stress (ranging from 1 to 24 plants per container).  Total seed count per plant (ranging 
from 0-293) and yield (ranging from 0.0-4.3 g) decreased with increasing population 
density; furthermore, the count and yield of malformed or immature seed also decreased 
with increasing density.  Additionally, the number of blooms per plant, bloom diameter, 
and mature seed count and yield were negatively correlated to density.  There was no 
significant effect of population density on flavonolignan content. 
Introduction 
Milk thistle is a medicinal plant whose use has been documented since ancient 
times as a treatment for liver and bile-related diseases, as well as acute Amanita 
mushroom poisoning (Fraschini et al., 2002; Kurkin, 2003).  Current studies have 
explored milk thistle’s use against various types of cancer, for cholesterol control, and for 
blood sugar control in those with type II diabetes (Gazak et al., 2007; Huseini et al., 
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2006).  Many of these benefits are attributed to the phenolic content of the plant’s leaves 
and seeds, which, like many secondary metabolites, are known to be affected by biotic 
and abiotic stress (Beckman, 2000; Sudha and Ravishankar, 2002).  The seeds contain a 
group of hepatoprotectant phenolic compounds known as flavonolignans.  
Flavonolignans are formed from a coupling of a flavonoid, taxifolin (dihydroquercetin), 
and a phenylpropanoid lignan component, coniferyl alcohol.  The primary bioactive 
flavonolignans include silybin A, silybin B, isosilybin A, isosilybin B, silychristin, and 
silydianin.  These compounds, along with taxifolin comprise the hepatoprotectant 
complex called silymarin.   
Since these valuable medicinal compounds are found primarily in the seeds, 
factors regulating seed production in milk thistle crops are important.  The relationship 
among blooms (or heads) and seed weight and count were described by Gabucci et al. 
(2002). The number of seeds per plant was positively correlated to the number of heads 
per plant.  The weight of the seeds per plant was positively correlated to the number of 
heads per plant, the number of seeds per head, and the individual seed weight.  In 
addition, the number of seeds per head increased with bloom diameter and decreased with 
the number of heads per plant. 
Population density and row spacing have been shown to have significant effects 
on the growth, yield, and flavonolignan concentrations in milk thistle.  Austin et al. 
(1988) showed that milk thistle harvested 6 weeks after planting had the highest shoot 
yield when planted at a density of 8 plants/pot (pot diameter = 18 cm).  At the next 
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density of 16 plants/pot, shoot yield began to decrease.  Omer et al. (1993) found that a 
narrow row spacing of 25 cm produced higher seed yields in milk thistle but lower oil 
and flavonolignan content compared to a wide row spacing of 50 cm.  Concentrations of 
silybin, silychristin, isosilybin, and silymarin were all significantly higher in the wider 
row spacing than the 25 cm row spacing. 
The objectives of this experiment were three-fold.  The first was to examine the 
effect of population density on plant growth and seed yield of milk thistle.  The second 
was to determine if population density stress affects the quality and quantity of silymarin 
in the seeds, and the third was to determine an optimum population density for seed and 
flavonolignan yield. 
Materials & Methods 
Plants were grown in 19 L (0.02 m3) poly grow bags (Hydro-Gardens, Colorado 
Springs, CO) in pine bark media (SunGro Horticulture, Bellvue, WA) with 15 mL (15.67 
g) 14-6-12 (N-P-K) Osmocote (Scotts-Sierra Horticultural Products Co., Marysville, 
OH).  Population density treatments were based on the number of seedlings planted per 
bag.  Densities were 1, 2, 4, 8, 12, 16, 20 and 24 plants per bag.  Bags were arranged in a 
randomized complete block (RCB) design consisting of two blocks with each treatment 
represented once per block. (Figures A-12 and A-13)  The plants were grown to maturity 
in a growth chamber with 16 hours of light at 1200 µmol/m2/s and 23 C and 8 hours of 
dark at 16 C.  Blooms were covered with drawstring bags post-anthesis.  At maturity the 
blooms were harvested, and growth data including blooms per plant, bloom diameter, 
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days to maturity, stem height, mature and immature seed number and weight were 
collected (Figure A-14).  Seed were stored at 4 C until analysis.   
Seed preparation and analysis was performed as detailed in Chapter III. 
(Procedures D-1 – D-4)  Growth and yield data, as well as flavonolignan and unknown 
compound concentrations were analyzed using simple linear regression, with the 
exception of bloom diameter which was analyzed with quadratic regression.  Statistical 
analysis was performed using SAS. 
Results 
All regression analyses were calculated using the actual numbers of plants 
harvested in each container.  Mortality was high in some of the original planned 
treatment densities, which resulted in different numbers of plants per container (Table B-
7).  Analysis showed a normal distribution of all growth and yield parameters against the 
treatments.  The number of blooms per plant (R2=0.43), bloom diameter (R2=0.59), 
number and weight of mature seeds (R2=0.54 and R2=0.53, respectively), number and 
weight of immature seeds (R2=0.43 and R2=0.29) and total number and weight of seeds 
(R2=0.62 and R2=0.55, respectively) were negatively correlated to plant density (P<0.05). 
(Figures A-15 – A-18)  All components of silymarin (taxifolin, silychristin, silydianin, 
silybin A and B, and isosilybin A and B) and unknown compounds were normally 
distributed.  However, none were significantly affected by population densities. (Table B-
8 & B-9)  Total levels of silymarin in seeds varied with population density, but not 
significantly (Figure A-19). 
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Discussion 
From this study it was concluded that increasing population density did not affect 
the quantity and quality of flavonolignans.  Decreased yield and overall plant vigor 
occurred when milk thistle was grown in high density conditions.  The decreased seed 
yields and numbers were consistent with lower bloom diameters and number of blooms 
per plant, as was previously described by Gabucci et al. (2002).  However, these findings 
disagree with seed yields and flavonolignan effects reported by Omer et al. (1993).  
Further research in this area could include population density effects in a field setting 
where root growth is not as restricted as in this experiment, and plants are exposed to 
sunlight as opposed to artificial light. 
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VI. Daily Water Rate Effects on Growth, Yield, and Flavonolignan 
Production 
Abstract 
 Milk thistle, Silybum marianum (L.) Gaertn., is a medicinal plant, grown 
worldwide, that contains hepatoprotectant phenolic compounds known as flavonolignans.  
These compounds are found primarily in the seeds and are collectively known as 
silymarin.  This study examined the effects of water stress on plant growth, seed yield, 
and flavonolignan content in milk thistle.  Plants were hydroponically grown under 
greenhouse conditions with varying daily water rates (200, 650, 1100, 1550, and 2000 
mL/day).  The lowest watering rate significantly reduced stem height (40.8 cm) and 
bloom diameter (2.3 cm).  The 1550 mL/day treatment had the highest stem height at 
106.3 cm, and the 1100 mL/day treatment had the largest bloom diameter at 2.9 cm.  The 
highest water treatment also showed the highest count of malformed or immature seeds 
(161 seeds/plant).  The 650 mL/day treatment had the lowest number of immature seeds 
with 62 seeds/plant.  The primary blooms were analyzed separately from the secondary 
blooms for flavonolignan content.  In primary blooms, the lowest water rate yielded the 
highest concentration of taxifolin (0.89 mg/g of seed meal).  In secondary blooms, 
flavonolignan content was not significantly affected. 
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Introduction 
Milk thistle grows worldwide and its use has been documented since ancient 
times as a treatment for liver and bile-related diseases, as well as acute Amanita 
mushroom poisoning (Fraschini et al., 2002; Kurkin, 2003).  In addition to 
antihepatotoxic actions, current studies have explored milk thistle’s use against various 
types of cancer, for cholesterol control, and for blood sugar control in those with type II 
diabetes (Gazak et al., 2007; Huseini et al., 2006).  The phenolic content of the plant’s 
leaves and seeds have been associated with these benefits.  Like many secondary 
metabolites, phenolics are known to be affected by biotic and abiotic stress (Beckman, 
2000; Sudha and Ravishankar, 2002).  Concentrated in the seeds are a group of 
hepatoprotectant phenolic compounds known as flavonolignans.  Flavonolignans are 
formed from the coupling of a flavonoid, taxifolin (dihydroquercetin), and a 
phenylpropanoid lignan component, coniferyl alcohol.  The primary bioactive 
flavonolignans include silybin A, silybin B, isosilybin A, isosilybin B, silychristin, and 
silydianin.  These compounds, along with taxifolin, comprise the hepatoprotectant 
complex known as silymarin. 
Silymarin levels have been documented to be affected by water availability.  
Hammouda et al. (1993) showed that silymarin levels were higher in plants grown at 60% 
field capacity compared to wild harvested plants.  Silydianin also decreased in plants 
grown under lower water conditions. 
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The objectives of this study were: 1) to examine the effects of water stress on 
plant growth and seed yield of milk thistle and the quality and quantity of silymarin in the 
seeds; and  2) to determine the irrigation rate needed to optimize seed yield and 
flavonolignan content. 
Materials & Methods 
This experiment was conducted in the greenhouse in 0.02 m3 poly grow bags 
(Hydro-Gardens, Colorado Springs, CO) filled with perlite.  Plants, planted one per bag, 
were subjected to five different watering regimes.  This experiment was set up in a 
randomized complete block (RCB) with four blocks to account for variation across the 
greenhouse.  Each block contained two single plant replications of each of the five 
watering treatments. (Figure A-20)  The treatments were controlled using spray irrigation 
emitters of different rates.  There was also an emitter in each bag that emitted a 
fertigation solution at a rate of 100 mL/day.  The fertigate was a mixture of 25% Chem-
Gro 4-8-31 (N-P-K) (Hydro-Gardens, Inc., Colorado Springs, CO), 25% fertilizer grade 
CaNO3, and 12.5% MgSO4. (Table B-10)  This mixture was further diluted with water to 
a ratio of 1:100 using fertilizer injectors.  Plants received 10.2 mg of nitrogen, 4.09 mg of 
phosphorus, and 16.4 mg of potassium per day.  The watering rates were as follows: 
2000, 1550, 1100, 650 and 200 mL/day (these rates include 100 mL of fertigation per 
day).  The plants grew and developed in this hydroponic system until flowering. (Figure 
A-21)  Cloth, drawstring bags were placed over the blooms as post-anthesis.  At maturity 
the blooms were harvested, and growth data including blooms per plant, bloom diameter, 
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days to maturity, stem height, mature and immature seed number and weight were 
collected.  Primary blooms from each plant were analyzed separately from all secondary 
blooms.  Secondary blooms were grouped together from each plant for analysis.  Seeds 
were stored at 4 C until analysis. 
Seeds were sterilized before starting extractions and analysis. (Procedure D-1)  
Extraction and analysis was performed as detailed in Chapter III. (Procedures D-2 – D-4)  
Statistical analysis was performed using SAS.  Growth and yield data, as well as 
flavonolignan and unknown compound concentrations were analyzed using mixed model 
ANOVA and LSD means separation.  SAS was used for all statistical analyses. 
Results 
Growth and yield data were analyzed using a RCB with replication model.  
Parameters of bloom diameter, stem height, and count of immature seeds were 
significantly affected by water treatments according to LSD means separation (P<0.05).  
Bloom diameter was smallest, at an average of 2.3 cm, in the 200 mL/day treatment and 
greatest in the 1100 mL/day treatment, with an average of 2.9 cm.  The other treatments 
did not change bloom diameter significantly from the 1100 mL/day treatment. (Figure A-
23)  Stem height was significant in the ANOVA analysis (P=0.0005) as well as mean 
separation.  Stems were shortest, at 40.8 cm, in the 200 mL/day treatment.  The 650 and 
2000 mL/day were statistically the same with an average stem height of 71.5 cm.  The 
1100 and 1550 mL/day treatments were also statistically the same with an average height 
of 123.3 cm. (Figure A-22 & Table B-12)  The immature seed count was also affected by 
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water treatments.  The 2000 mL/day treatment was significantly different from the 1550 
and 650 mL/day treatment (averages were 161 and 63 immature seeds per plant, 
respectively).  The other treatments did not differ and had an average of 84 immature 
seeds per plant. (Figure A-24)  Yield data was not significant. (Table B-11) 
Primary and secondary blooms were analyzed for flavonolignan content using a 
RCB with replication and sampling.  In primary blooms, taxifolin concentrations were 
significantly affected with the highest concentration (0.89 mg/g) in the 200 mL/day 
treatment and the lowest concentration (0.47 mg/g) in the 650 mL/day treatment.  The 
other treatments did not differ significantly from each other and had an average taxifolin 
concentration of 0.64 mg/g. (Figure A-25)  Water level did not significantly affect 
flavonolignans in secondary blooms.  Water level did not significantly influence 
silymarin content in primary or secondary blooms. (Figures A-26 and A-27) 
Discussion 
 Plant growth and secondary metabolite concentrations have been documented to 
be affected by water stress.  In a study of Japanese mint (Mentha arvensis), researchers 
found that water stress, from unstressed levels to acute stress levels, reduced plant height 
(51.5 to 39.7 cm, respectively) and leaf length (4.8 to 3.5, respectively).  Terpenoid 
essential oil levels (menthol, menthone, and methyl acetate) were highest at mild stress 
levels (30% field moisture capacity) at 0.58% fresh weight.  Essential oil levels were 
significantly lowered by acute water stress (10% field moisture capacity) to 0.40% fresh 
weight. (Misra and Srivastava, 2000) 
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From this study it was concluded that different daily water rates has minimal 
effect on the quantity and quality of flavonolignans in milk thistle.  The minor growth 
differences observed between treatments and the lack of effect on days for plants to reach 
maturity suggest that conditions of true water stress were not reached in this experiment.  
Cell growth has been determined to be the first process that declines when a plant 
undergoes water stress.  Closely related to growth in being restricted by water stress is 
cell division. (Hsiao et al., 1976)  These processes were slowed in the lowest water 
treatment, as stem height and bloom diameter were affected.  While the lowest water rate 
did affect stem height and bloom diameter, it had no effect on mature seed count or yield.  
Therefore, the lowest water treatment did not have a major effect on overall plant vigor.  
The results indicated that milk thistle can be grown with minimal input of water without 
decreasing yield or flavonolignan content.   
Furthermore, the literature suggests that milk thistle is not susceptible to many 
insect and disease pressures in field production.  While this may be true, in greenhouse 
production insect pressure was great.  White flies and aphids were both troublesome. 
(Figure A-28)
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VII. Summary & Overall Conclusions 
Flavonolignan Content 
 Growth and yield of milk thistle was affected, typically reduced, with increasing 
stress.  However, flavonolignan concentrations were largely unaffected by environmental 
stresses studied here.  From a production standpoint, flavonolignan content per plant or 
per unit area may be a more useful calculation.  Despite reduction in overall growth or 
yield, silymarin content produced per unit area (in these experiments unit area = 4 ft2 = 
0.37 m2) may be increased.   
When silymarin content was calculated for the preliminary experiment with the 
data from the three leaf removal treatments, basal leaf removal yielded 362 mg/4 ft2.  
Cauline leaf removal yielded 334 mg/4 ft2, and the plants with no leaves removed yielded 
687 mg/4 ft2.  These plants were grown in 4” Speedling trays, therefore, a 4 ft2 area 
represents 36 plants.   
In the population density study, flavonolignan content varied from 29.0 mg/bag (6 
plants/bag) to 285 mg/bag (12 plants/bag).  The median content was 147 mg/bag (11 
plants/bag).  Each bag represents roughly 4 ft2 (this includes the bag diameter of 1 ft plus 
1 ft spacing between bags). 
 Content calculations for the water experiment resulted in the following results:  
200 mL/day had 204 mg/bag, 650 mL/day had 238 mg/bag, 1100 mL/day had 530 
mg/bag, 1550 mL/day had 585 mg/bag, and 2000 mL/day had 391 mg/bag.  Again, each 
bag plus spacing between bags is 4 ft2. 
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In the water stress experiment, the time from planting to harvest was 
approximately one year.  The preliminary experiment reached maturity in approximately 
four months.  If milk thistle plants grown in small containers could be harvested every 
four months, it would be possible to reach a total silymarin yield of 2061 mg/4 ft2/year.  
This surpasses the yield potential of plants under any of the water stress treatments. 
Other Considerations 
UV Light 
Flavonolignans in milk thistle were not significantly affected by population 
density or water stress.  Several concepts may explain the lack of significant effects.  
Flavonolignans may function in the plant to protect from UV radiation.  In human 
keratinocytes, silymarin has shown to reduce UVA-induced damage by reducing the 
amount of reactive oxygen species formed and reducing lipid peroxidation. (Svobodova 
et al., 2007)  Silymarin could function in similar ways in plant cells as well.  To study 
population density and water stress, plants were grown in greenhouses and growth 
chambers.  Neither of these controlled environments have high incidence of UV light.  
The absence of UV light may have reduced the amount of flavonolignans formed.   
Conjugated Flavonolignans 
Warren (2003) found bioactivity in milk thistle roots, stems, and leaves in the 
potato disk bioassay, but CE analysis did not detect pure flavonolignan compounds in 
these vegetative extracts.  Other studies have found that flavonolignans can be 
compounded with carbohydrate or lipid compounds.  Synthesized silybin glycosides have 
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shown to have strong antioxidant properties on hepatocytes in culture, although 
antioxidant capacity was reduced compared to that of silybin.  However, overall 
solubility and bioavailability was greater in the glycosides than in the pure compound. 
(Kosina et al., 2002)  Flavonolignan glycosides may exist in the roots, stems, and leaves 
of milk thistle.  The improved solubility of the flavonolignan glycosides could improve 
compound mobility in the plant and could concentrate in areas experiencing stress. 
Similarly, flavonolignans may exist in lipid forms.  Studies have shown that 
flavonolignans coupled with phosphatidylcholine, a phospholipid, improved 
bioavailability in the body. (Kidd and Head, 2005)  Flavonolignans have also been shown 
to stabilize cell membranes in the liver to prevent the entrance of toxins into liver cells. 
(Fraschini et al., 2002)  A similar action could occur in milk thistle cell membranes as 
well, preserving membrane integrity in occurrence of stress.  Unsaturated phospholipids 
in cell membranes can be easily oxidized.  Therefore, a lipid-bound flavonolignan could 
interact with and provide antioxidant effects directly to the cell membrane. 
Both of these proposed flavonolignan forms could exist in the plant and provide 
an explanation of the role of flavonolignans in the plant.  If these compounds did exist in 
vegetative tissue, milk thistle could be grown for a short time in the basal stage, and then 
vegetative growth could be bulk-harvested for flavonolignan extraction.  This would 
shorten the time between planting and harvesting to obtain the beneficial compounds. 
Further Research 
Further research should include antioxidant screenings of both lipid- and water-
soluble fractions of milk thistle vegetative tissue.  Also, a study should examine potential 
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differences in flavonolignan profiles in plants grown in a controlled environment to 
those grown in the field where UV light radiation would be high.  These experiments 
would greatly benefit flavonolignan production for medicinal use as well as propose a 
role for flavonolignans within the milk thistle plant. 
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Figure A-1:  Chemical structures of silymarin components found in milk thistle 
seeds.
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Figure A-2:  Silybum marianum in flower in preliminary experiment.  Plants are 
growing in 4-inch polystyrene trays. 
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Figure A-3:  Effect of single leaf removal treatments on plant height in milk thistle 
(Silybum marianum) seeds.  Data analyzed with mixed model ANOVA.  LSD means 
separation shown (P<0.05).   
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Figure A-4:  Effect of single leaf removal treatments on number of mature seeds in 
milk thistle (Silybum marianum).  Data analyzed with mixed model ANOVA.  LSD 
means separation shown (P<0.05). 
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Figure A-5: Effect of single leaf removal treatments on mature and total seed weights in milk thistle (Silybum 
marianum).  Data analyzed with mixed model ANOVA.  LSD means separation shown (P<0.05).
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Figure A-6: Effect of single leaf removal treatments on concentrations of silymarin components in milk thistle (Silybum 
marianum) seeds.  Data analyzed with mixed model ANOVA.  LSD means separation shown (P<0.05). * denotes 
significantly affected component. 
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Figure A-7: Effect of single leaf removal treatments on total levels of silymarin in milk thistle (Silybum marianum) 
seeds.  Data analyzed with mixed model ANOVA.  LSD means separation shown (α=0.05). 
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Figure A-8: Effect of single leaf removal treatments on concentrations of unknown compounds in milk thistle (Silybum 
marianum) seeds.  Data analyzed with mixed model ANOVA.  LSD means separation are shown (α=0.05). * denotes 
significantly affected unknown compounds.
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Figure A-9: Concentration of silymarin components in various sources of milk thistle (Silybum marianum) seeds.   Seed 
sources were as follows: F=Frontier; FO=Frontier (Organic); JS=Johnny’s Select; R=Richters Herbs; SM=Stony 
Mountain Botanicals; UB=University of Belgrade; WWC=Wild Weeds (Croatia); WWO=Wild Weeds (Oregon).  Seed 
sources were significantly different based on mixed model ANOVA.  Tukey means separation is shown at P<0.05.   
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Figure A-10: Flavonolignan profile in various sources of milk thistle (Silybum marianum) seeds.  Seed sources were as 
follows: F=Frontier; FO=Frontier (Organic); JS=Johnny’s Select; R=Richters Herbs; SM=Stony Mountain Botanicals; 
UB=University of Belgrade; WWC=Wild Weeds (Croatia); WWO=Wild Weeds (Oregon).  All components were 
significantly different based on mixed model ANOVA (P<0.05). 
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Figure A-11: Total concentrations of silymarin in various sources of milk thistle (Silybum marianum) seeds.  Seed 
sources were as follows: F=Frontier; FO=Frontier (Organic); JS=Johnny’s Select; R=Richters Herbs; SM=Stony 
Mountain Botanicals; UB=University of Belgrade; WWC=Wild Weeds (Croatia); WWO=Wild Weeds (Oregon).  Total 
concentrations were significantly different based on mixed model ANOVA.  Tukey means separation is shown at 
P<0.05.
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Figure A-12:  Experimental design for population density effects on growing plants.  
Each number represents the number of plants contained in each growth bag. 
 
 
 
Figure A-13:  One block of all population density treatments of milk thistle (Silybum 
marianum) between true leaf stages 10-20. 
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Figure A-14: Growth data collection and seed harvest of milk thistle (Silybum 
marianum) in population density treatments in walk-in growth chamber. 
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Figure A-15: Number of blooms per plant in milk thistle (Silybum marianum) grown 
at different numbers of plants per container (R2=0.59).  Data analyzed using 
quadratic regression (P<0.05). 
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Figure A-16: Bloom diameter in milk thistle (Silybum marianum) grown at different 
numbers of plants per container (R2=0.72).  Data analyzed using simple linear 
regression (P<0.05). 
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Figure A-17: Number of mature seeds in milk thistle (Silybum marianum) grown at 
different numbers of plants per container (R2=0.54).  Data analyzed using simple 
linear regression (P<0.05). 
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Figure A-18: Weight of mature seeds in milk thistle (Silybum marianum) grown at 
different numbers of plants per container (R2=0.53).  Data analyzed using simple 
linear regression (P<0.05). 
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Figure A-19: Silymarin concentration in milk thistle (Silybum marinanum) seeds from varying population densities.  
Concentrations were not significant using simple linear regression at P<0.05. 
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Figure A-20:  Experimental design for water stress experiment.  Each number 
represents a treatment level.  100 mL of each treatment/day is fertigate. 
Treatment # Treatment 
1 200 mL/day 
2 650 mL/day 
3 1100 mL/day 
4 1550 mL/day 
5 2000 mL/day 
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Figure A-21: Hydroponic apparatus in greenhouse used to determine the effects of 
water stress on milk thistle (Silybum marianum) plants. 
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Figure A-22: Average stem height per plant in milk thistle (Silybum marianum) grown under varying daily water rates.  
Data analyzed using RBD with replication model.  LSD means separation is shown (significance at P<0.05). 
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Figure A-23: Average bloom diameter per plant in milk thistle (Silybum marianum) grown under varying daily water 
rates.  Data analyzed using RBD with replication model.  LSD means separation is shown (significance at P<0.05). 
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Figure A-24: Average count of immature seeds per plant in milk thistle (Silybum marianum) grown under varying daily 
water rates.  Data analyzed using RBD with replication model.  LSD means separation is shown (significance at 
P<0.05). 
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Figure A-25: Taxifolin concentration in primary blooms of milk thistle (Silybum marianum) grown under varying daily 
water rates.  Concentration is in mg of taxifolin per g of seed meal.  Data analyzed using RBD with replication and 
sampling model.  LSD means separation is shown (significance at P<0.05). 
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Figure A-26: Silymarin concentration in primary blooms of milk thistle (Silybum marianum) grown under varying daily 
water rates.  Concentration is in mg of taxifolin per g of seed meal.  Data analyzed using RBD with replication and 
sampling model.  Silymarin concentrations were not significantly different at P<0.05. 
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Figure A-27: Silymarin concentration in secondary blooms of milk thistle (Silybum marianum) grown under varying 
daily water rates.  Concentration is in mg of taxifolin per g of seed meal.  Data analyzed using RBD with replication 
and sampling model.  Silymarin concentrations were not significantly different at P<0.05. 
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Figure A-28: Aphids and whiteflies on a milk thistle (Silybum marianum) leaf in 
hydroponic greenhouse production. 
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Table B-1:  Solvent gradient for HPLC analysis of milk thistle (Silybum marianum) seeds. 
Time Solvent A Solvent B 
(min) (CH3OH:H2O) (CH3OH:H2O) 
0 85 15 
5 85 15 
20 45 55 
35 45 55 
38 0 100 
43 0 100 
44 85 15 
Solvent A is 20% CH3OH and 80% H2O 
Solvent B is 80% CH3OH and 20% H2O 
Time is in minutes 
 
Table B-2: Growth and yield parameters of milk thistle (Silybum marianum) in different single leaf removal treatments. 
Removal 
Stem Height 
(cm)* 
# Mature 
Seeds* 
# Immature 
Seeds 
Total # 
Seeds* 
Mature Seed 
Weight (g)* 
Immature Seed 
Weight (g) 
Total Seed 
Weight (g)* 
Days to 
Maturity 
Basal Leaf 26.0 ± 3.1  B 16 ± 8  B 8 ± 7 24 ± 7  AB 0.399 ± 0.151  B 0.033 ± 0.043 0.432 ± 0.132  B 154 ±  1 
Cauline Leaf 25.0 ± 4.5  B 13 ± 6  B 6 ± 3 19 ± 7    B 0.319 ± 0.175  B 0.021 ± 0.027 0.340 ± 0.167  B 149 ± 10 
No Removal 32.6 ± 4.2  A 22 ± 8  A 11 ± 16 33  ± 14  A 0.621 ± 0.188  A 0.034 ± 0.061 0.654 ± 0.172  A 147 ± 11 
* denotes statistical significance at P<0.05 by mixed model ANOVA. 
Means separation by LSD (P<0.05). 
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Table B-3: Concentrations of silymarin and silymarin components in milk thistle (Silybum marianum) seeds in different 
single leaf removal treatments. 
Removal Taxifolin* Silychristin Silydianin Silybin A Silybin B Isosilybin A Isosilybin B Total 
Basal Leaf 0.95 ± 0.26 3.31 ± 0.33 12.02 ± 2.80 1.43 ± 0.16 1.37 ± 0.15 3.61 ± 0.38 2.50 ± 0.29 25.20 ± 4.06 
Cauline Leaf 0.98 ± 0.30 4.27 ± 0.69 13.46 ± 1.81 1.72 ± 0.23 1.54 ± 0.23 4.26 ± 0.64 2.83 ± 0.49 29.06 ± 3.97 
No Removal 1.43 ± 0.21 4.48 ± 0.75 14.22 ± 1.87 2.19 ± 1.11 1.75 ± 0.71 4.18 ± 0.39 2.49 ± 0.63 30.73 ± 3.02 
concentrations in mg of compound/g of seed meal. 
* denotes statistical significance at P<0.05 by mixed model ANOVA. 
 
 
Table B-4: Concentrations of unknown compounds in milk thistle (Silybum marianum) seeds in different single leaf 
removal treatments. 
Removal Unk 2 Unk 3* Unk 4* Unk 6 Unk 7* Unk 8 
Basal Leaf 0.00 ± 0.00 1.77 ± 0.42 0.10 ± 0.03 3.28 ± 0.45 7.10 ± 0.83 0.00 ± 0.00 
Cauline Leaf  0.11 ± 0.21 2.26 ± 0.46 0.07 ± 0.03 3.70 ± 0.61 9.13 ± 1.53 0.00 ± 0.00 
No Removal 0.02 ± 0.08 2.58 ± 0.44 0.11 ± 0.03 3.90 ± 0.46 7.79 ± 1.15 0.23 ± 0.62 
concentrations in mg of compound per g of seed meal. 
* denotes statistical significance at P<0.05 by mixed model ANOVA. 
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Table B-5: Concentrations of silymarin components in various sources of milk thistle (Silybum marianum) seeds. 
Sources Taxifolin Silychristin Silydianin Silybin A Silybin B Isosilybin A Isosilybin B Total 
F 1.32 ± 0.02  13.75 ± 0.67  4.19 ± 0.11 15.68 ± 1.32 10.89 ± 0.88 3.92 ± 0.33 1.66 ± 0.05 51.41 ± 3.34 
FO 2.07 ± 0.27 6.20 ± 0.20 15.25 ± 0.15 2.97 ± 0.19 2.36 ± 0.09 3.79 ± 0.04 2.56 ± 0.09 35.19 ± 0.21 
JS 1.50 ± 0.01 4.34 ± 0.54 13.91 ± 0.48 2.19 ± 0.20 1.93 ± 0.12 3.40 ± 0.24 2.34 ± 0.06 29.60 ± 1.66 
R 2.18 ± 0.12 9.50 ± 0.64 5.03 ± 0.59 10.33 ± 0.69 7.36 ± 0.39 3.25 ± 0.29 1.50 ± 0.06 39.15 ± 2.79 
SM 1.17 ± 0.11 15.51 ± 0.19 4.09 ± 0.49 17.33 ± 0.31 12.47 ± 0.22 4.47 ± 0.33 1.87 ± 0.37 56.90 ± 0.99 
UB 0.95 ± 0.01 4.50 ± 0.25 16.50 ± 0.59 1.54 ± 0.14 1.58 ± 0.11 4.31 ± 0.33 3.07 ± 0.25 32.45 ± 1.69 
WWC 1.03 ± 0.03 6.44 ± 0.11 13.41 ± 0.45 4.87 ± 0.33 3.75 ± 0.17 3.97 ± 0.03 2.39 ± 0.01 35.86 ± 0.15 
WWO 1.24 ± 0.08 7.77 ± 0.10 10.03 ± 1.25 7.55 ± 0.00 5.48 ± 0.02 3.87 ± 0.22 2.29 ± 0.18 38.23 ± 1.82 
Seed sources were as follows: F=Frontier; FO=Frontier (organic); JS=(Johnny’s Select); R=Richters Herbs; SM=Stony 
Mountain Botanicals; UB=University of Belgrade; WWC=Wild Weeds (Croatia); WWO=Wild Weeds (Oregon). 
Concentrations are in mg compound per g seed meal.  All silymarin compounds were significantly affected by seed source by 
mixed model ANOVA at P<0.05. 
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Table B-6: Concentrations of unknown compounds in various sources of milk thistle (Silybum marianum) seeds. 
Sources Unk 2 Unk 3 Unk 4 Unk6 Unk 7 Unk 8 
F 0.24 ± 0.04 2.54 ± 0.42 0.17 ± 0.01 5.79 ± 0.66 3.91 ± 0.12 5.91 ± 0.12 
FO 0.14 ± 0.02 1.68 ± 0.22 0.17 ± 0.01 5.84 ± 0.04 7.55 ± 0.47 0.00 ± 0.00 
JS 0.09 ± 0.13 1.81 ± 0.81 0.10 ± 0.02 3.93 ± 0.25 6.42 ± 0.79 0.00 ± 0.00 
R 0.00 ± 0.00 1.66 ± 0.26 0.39 ± 0.04 4.75 ± 0.14 3.89 ± 0.47 3.28 ± 0.39 
SM 0.21 ± 0.01 2.66 ± 0.00 0.15 ± 0.02 3.95 ± 0.30 4.08 ± 0.14 6.56 ± 1.50 
UB 0.22 ± 0.05 2.47 ± 0.37 0.10 ± 0.04 3.78 ± 0.73 7.90 ± 0.63 0.00 ± 0.00 
WWC 0.25 ± 0.06 2.10 ± 0.48 0.13 ± 0.03 4.19 ± 0.03 6.51 ± 0.20 2.20 ± 0.09 
WWO 0.27 ± 0.00 1.74 ± 0.08 0.15 ± 0.03 4.13 ± 0.41 5.48 ± 0.44 2.75 ± 0.11 
Seed sources were as follows: F=Frontier; FO=Frontier (organic); JS=(Johnny’s Select); R=Richters Herbs; SM=Stony 
Mountain Botanicals; UB=University of Belgrade; WWC=Wild Weeds (Croatia); WWO=Wild Weeds (Oregon). 
Concentrations are in mg compound per g seed meal.  All unknown compounds were significantly affected by seed source by 
mixed model ANOVA at P<0.05. 
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Table B-7: Growth and yield parameters of milk thistle (Silybum marianum) at different populations of plants per 
container. 
Plants per 
Container 
Blooms per 
Plant* 
Bloom Diameter 
(cm)* 
# Mature 
Seeds* 
# Immature 
Seeds 
Total # 
Seeds* 
Mature Seed 
Weight (g)* 
Immature Seed 
Weight (g) 
Total Seed 
Weight (g)* 
1 2 2.6 71 159 230 1.920 0.158 2.079 
1 6 n/a 144 149 293 4.015 0.207 4.222 
2 4 1.9 36 170 206 0.978 0.344 1.322 
2 4 n/a 117 43 159 2.717 0.062 2.779 
3 2 2.0 72 40 112 1.998 0.104 2.102 
4 2 n/a 54 25 79 1.107 0.027 1.134 
6 1 1.6 10 40 50 0.234 0.062 0.296 
8 2 1.8 33 32 65 0.820 0.048 0.867 
8 2 2.0 34 40 74 0.872 0.047 0.919 
11 1 1.5 19 21 40 0.441 0.026 0.467 
12 1 1.6 25 34 59 0.619 0.065 0.684 
15 1 1.5 24 22 46 0.576 0.023 0.599 
16 1 1.2 4 23 27 0.095 0.029 0.124 
17 1 1.2 9 15 25 0.246 0.020 0.266 
18 1 1.4 10 22 32 0.231 0.042 0.272 
20 1 1.4 17 24 41 0.376 0.098 0.474 
* denotes statistical significance at P<0.05 by simple linear regression. 
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Table B-8: Concentration of silymarin and individual flavonolignans in milk thistle (Silybum marianum) seeds at 
different populations of plants per container. 
Plants per 
Container Taxifolin Silychristin Silydianin Silybin A Silybin B Isosilybin A Isosilybin B 
Total 
Silymarin 
1 2.26 9.68 0.71 11.48 7.49 2.26 0.68 34.55 
2 2.07 4.59 8.74 4.68 3.22 2.63 1.42 27.35 
3 2.60 7.54 4.58 8.58 5.75 2.47 1.13 32.64 
4 2.80 9.32 1.29 10.74 7.59 2.37 0.76 34.88 
6 1.73 3.66 5.62 4.35 2.56 1.88 0.84 20.63 
8 2.97 6.78 3.44 8.80 5.54 2.22 0.97 30.73 
11 2.80 6.41 1.45 9.86 6.75 2.21 0.73 30.21 
12 3.89 9.49 2.95 11.55 7.03 2.55 0.90 38.35 
15 2.01 5.82 5.09 6.97 4.54 2.26 1.05 27.74 
16 2.47 6.58 6.82 7.51 5.35 2.76 1.32 32.81 
17 2.63 6.21 5.29 7.56 5.06 2.47 1.11 30.34 
18 3.12 6.95 4.85 8.62 5.90 2.65 1.16 33.24 
20 18.63 7.87 3.79 9.40 6.19 2.56 1.14 32.23 
Concentration in mg compound per gram of seed meal.  No flavonolignan concentrations were significant using simple linear 
regression at P<0.05. 
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Table B-9: Concentration of unknown compounds in milk thistle (Silybum marianum) seeds at different populations of 
plants per container. 
Plants per 
Container Unk 1 Unk 2 Unk 3 Unk 4 Unk 5 Unk6 Unk 7 Unk 8 
1 0.02 0.26 0.99 0.07 0.04 2.03 1.30 8.87 
2 0.03 0.29 1.09 0.06 0.19 3.36 2.48 1.20 
3 0.05 0.33 0.99 0.06 0.28 3.13 2.10 2.22 
4 0.03 0.48 1.23 0.06 0.08 2.46 1.22 2.36 
6 0.04 0.25 0.80 0.06 0.01 2.67 1.44 0.87 
8 0.04 0.42 1.08 0.06 0.07 2.70 1.76 1.51 
11 0.04 0.38 0.91 0.07 0.00 1.95 1.28 2.77 
12 0.04 0.40 1.17 0.06 0.15 3.07 1.77 2.08 
15 0.05 0.46 1.11 0.05 0.10 2.73 1.86 1.57 
16 0.04 0.38 1.12 0.07 0.16 3.21 2.01 1.48 
17 0.04 0.38 1.17 0.06 0.17 3.30 1.86 1.40 
18 0.04 0.41 1.25 0.07 0.00 3.11 1.91 1.70 
20 0.04 0.42 1.23 0.05 0.17 2.78 1.92 2.30 
Concentration in mg of compound per gram of seed meal.  No flavonolignan concentrations were significant using simple 
linear regression at P<0.05. 
  
 
111
Table B-10: Elemental content of fertilizer concentrate (mg/L) used to fertigate 
milk thistle (Silybum marianum) in a hydroponic experiment with different water 
rates. 
Elements   PPM 
Total N   10187.147 
Ammonia N   675.559 
Phosphorus   4085.55 
Potassium   16407.418 
Calcium   9663.236 
Magnesium   5253.177 
Sulfur   6592.815 
Iron   208.037 
Manganese   104.021 
Zinc   25.994 
Boron   104.021 
Copper   25.99 
Molybdenum   5.201 
Chlorine   1040.215 
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Table B-11: Six yield parameters of milk thistle (Silybum marianum) at different daily water rates. 
Treatment 
(mL/day) 
Mature Seed 
Count 
Immature Seed 
Count 
Total Seed 
Count 
Mature Seed 
Weight (g) 
Immature Seed 
Weight (g) 
Total Seed 
Weight (g) 
200 274 ± 88     67 ± 49 AB1 341 ± 131 5.896 ± 2.358   0.241 ± 0.191 6.137 ± 2.537 
650 305 ± 197 62 ± 51 B 367 ± 205 7.104 ± 4.985 0.171 ± 0.207 7.275 ± 5.007 
1100 657 ± 348 102 ± 73 AB  758 ± 411 15.911 ± 9.989 0.392 ± 0.353 16.303 ± 10.224 
1550 643 ± 366 64 ± 37 B 708 ± 381 15.934 ± 9.969 0.241 ± 0.220 16.175 ± 10.038 
2000 624 ± 568 161 ± 153 A 785 ± 681 15.527 ± 15.478 0.433 ± 0.373 15.960 ± 15.663 
LSD means separation shown (P<0.05).  All other parameters were not significant at P<0.05. 
 
 
 
 
Table B-12: Growth data of milk thistle (Silybum marianum) at different daily water rates. 
Treatment 
(mL/day) 
Number of 
Blooms per Plant 
Bloom Diameter 
(cm) 
Stem Height  
(cm) 
Days to  
Maturity 
200 4 ± 3 2.3 ± 0.4   B1 40.8 ± 11.0   C 289 ± 30 
650 4 ± 2 2.5 ± 0.5  AB 68.8 ± 23.1   B 301 ± 12 
1100 7 ± 4 2.9 ± 0.5   A 104.2 ± 24.7  A 307 ± 10 
1550 6 ± 3 2.8 ± 0.4  AB 106.2 ± 18.9  A 301 ± 15 
2000 6 ± 4 2.7 ± 0.6  AB 74.3 ± 24.3   B 296 ± 25 
LSD means separation shown (P<0.05).  All other parameters were not significant at P<0.05. 
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Appendix C: Chromatographs and DAD Spectra 
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Figure C-29: Chromatograph of taxifolin standard 
 
 
 
 
Figure C-30: Spectra for taxifolin standard 
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Figure C-31: 3-D spectra of taxifolin standard 
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Figure C-32: Chromatograph of silybin standard (with silybin A and B) 
 
 
 
Figure C-33: Spectra for silybin A 
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Figure C-34: Spectra for silybin B 
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Figure C-35: 3-D spectra of silybin A 
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Figure C-36: 3-D spectra of silybin B 
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Figure C-37: Chromatograph of  hesperetin (internal standard) 
 
 
 
Figure C-38: Spectra for hesperetin 
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Figure C-39: 3-D spectra of hesperetin 
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Figure C-40: HPLC chromatograph of silymarin profile of milk thistle (Silybum marianum) grown at a density of two 
plants per container.  TX=taxifolin; SC=silychristin; SD=silydianin; SA=silybin A; SB=silybin B; HE=hesperetin; 
ISA=isosilybin A; ISB=isosilybin B. 
  
 
TX
SC
SD 
SA 
SB HE
ISA
ISB
  
 
123
 
 
 
 
 
 
 
Figure C-41: HPLC chromatograph of unknown compounds in milk thistle (Silybum marianum) seeds grown at a 
density of two plants per container.  U3=unknown 3; U4=unknown 4; U5=unknown 5; U6=unknown 6; U7=unknown 7; 
U8=unknown 8. 
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Figure C-42: HPLC chromatograph of silymarin profile of milk thistle (Silybum marianum) grown at a density of four 
plants per container.  TX=taxifolin; SC=silychristin; SD=silydianin; SA=silybin A; SB=silybin B; HE=hesperetin; 
ISA=isosilybin A; ISB=isosilybin B. 
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Figure C-43: HPLC chromatograph of unknown compounds in milk thistle (Silybum marianum) seeds grown at a 
density of four plants per container. U1= unknown 1; U2=unknown 2; U3=unknown 3; U4=unknown 4; U5=unknown 
5; U6=unknown 6; U7=unknown 7; U8=unknown 8. 
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Figure C-44: HPLC chromatograph of silymarin profile of milk thistle (Silybum marianum) grown at a density of eight 
plants per container.  TX=taxifolin; SC=silychristin; SD=silydianin; SA=silybin A; SB=silybin B; HE=hesperetin; 
ISA=isosilybin A; ISB=isosilybin B. 
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Figure C-45: HPLC chromatograph of unknown compounds in milk thistle (Silybum marianum) seeds grown at a 
density of eight plants per container. U1= unknown 1; U2=unknown 2; U3=unknown 3; U4=unknown 4; U5=unknown 
5; U6=unknown 6; U7=unknown 7; U8=unknown 8. 
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Figure C-46: HPLC chromatograph of silymarin profile the secondary blooms of a milk thistle (Silybum marianum) 
plant grown at water rate of 2000 mL/day.  TX=taxifolin; SC=silychristin; SD=silydianin; SA=silybin A; SB=silybin B; 
HE=hesperetin; ISA=isosilybin A; ISB=isosilybin B. 
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Figure C-47: HPLC chromatograph of unknown compounds in seeds from secondary blooms of a milk thistle (Silybum 
marianum) plant grown at water rate of 2000 mL/day.  U2=unknown 2; U3=unknown 3; U4=unknown 4; U6=unknown 
6; U7=unknown 7. 
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Figure C-48: HPLC chromatograph of silymarin profile the secondary blooms of a milk thistle (Silybum marianum) 
plant grown at water rate of 650 mL/day.  TX=taxifolin; SC=silychristin; SD=silydianin; SA=silybin A; SB=silybin B; 
HE=hesperetin; ISA=isosilybin A; ISB=isosilybin B. 
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Figure C-49: HPLC chromatograph of unknown compounds in seeds from secondary blooms of milk thistle (Silybum 
marianum) grown at water rate of 650 mL/day. U2=unknown 2; U3=unknown 3; U4=unknown 4; U6=unknown 6; 
U7=unknown 7; U8=unknown 8. 
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Figure C-50: HPLC chromatograph of silymarin profile of milk thistle (Silybum marianum) seeds from Frontier 
Natural Products Co-op.  TX=taxifolin; SC=silychristin; SD=silydianin; SA=silybin A; SB=silybin B; HE=hesperetin; 
ISA=isosilybin A; ISB=isosilybin B. 
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Figure C-51: HPLC chromatograph of unknown compounds in milk thistle (Silybum marianum) seeds from Frontier 
Natural Products Co-op.  U2=unknown 2; U3=unknown 3; U4=unknown 4; U6=unknown 6; U7=unknown 7; 
U8=unknown 8.
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Appendix D: Procedures
  
 
135
Procedure D-1: Seed Sterilization Procedure 
1. Cheese cloth squares (approximately 6 cm x 6 cm) were cut to hold seeds in 
during sterilization treatments.  Squares were wrapped around seeds and secured 
with a rubber band. 
2. Groups of seeds were placed in beakers and covered with a 70% ethanol solution 
and placed on a shaker for 2 minutes. 
3. After 2 minutes, ethanol was poured off and seeds were washed with water three 
times. 
4. Seeds were placed back into rinsed beakers and covered with a 5% bleach 
solution, containing 1% sodium dodecyl sulfate (SDS) by weight.  These were 
placed on the shaker for 15 minutes. 
5. After 15 minutes, the bleach solution was poured off and seeds were rinsed 
thoroughly with water. 
6. Seeds were then lain out on paper towels to dry if in preparation for HPLC 
analysis.  If seeds were sterilized in preparation to be germinated for an 
experiment, seeds were then placed in a beaker of hot water for 12-16 hours for 
imbibition preceding germination. 
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Procedure D-2: Flavonolignan Extraction from Silybum marianum for HPLC 
Analysis 
Procedure modified from Wallace, S., D.J. Carrier, R.R. Beitle, E.C. Clausen and C.L. 
Griffis. 2003. J Nutraceut Function Med Foods. 4(2): 37-48. 
1. Grind seeds in coffee mill to 20 mesh. 
2. Weigh 100 mg ground seed sample into 1.5 mL amber microcentrifuge tube. 
3. Add 0.5 mL (5:1, solvent: sample) petroleum ether to microcentrifuge tube. 
4. Vortex. 
5. Sonicate for 30 minutes. 
6. Vortex. 
7. Centrifuge for 10 minutes at 2000 RCF. 
8. Decant supernatant. 
9. Add 0.5 mL methanol to microcentrifuge tube. 
10. Vortex. 
11. Sonicate for 20 minutes. 
12. Vortex. 
13. Centrifuge for 10 minutes at 2000 RCF. 
14. Decant supernatant into 15 mL test tube and cap.  Protect collected supernatant 
from light. 
15. Repeat steps 9-15 three times. 
16. Evaporate collected supernatant to dryness under N2 stream. 
  
 
137
17. Add 1mL methanol. 
18. Add 100 µL of hesperetin internal standard (1.0 mg/mL stock solution) 
19. Vortex. 
Filter through 0.45µm syringe filter into amber crimp-top HPLC sample vials. 
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Procedure D-3: HPLC Parameters 
HPLC: 
 Agilent 1100 (Agilent Technologies, Santa Clara, CA) 
 
Detector: 
 Diode array detector (DAD) with 3-D spectra 
 
Column: 
 Luna C-18(2) (250 x 4.6 mm, 5 µm) (Phenomenex, Torrance, CA) 
 
Column temperature: 
 40 C 
 
Mobile phases: 
 A: 20:80 methanol: water 
 B: 80:20 methanol: water 
 
Flow rate: 
 0.8 mL/min 
 
Injection volume:  
 25 µL 
 
Solvent gradient: 
  
Time Solvent A Solvent B 
(min) (CH3OH:H2O) (CH3OH:H2O) 
0 85 15 
5 85 15 
20 45 55 
35 45 55 
38 0 100 
43 0 100 
44 85 15 
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Procedure D-4: Determination of Flavonolignan Concentration in Silybum 
marianum seeds from HPLC Analysis Data 
 Flavonolignan concentrations were determined using an internal standard method.  
The internal standard (IS) used was hesperetin, a flavonoid common in citrus.  Each 
sample had 100 µL of 1.0 mg/mL hesperetin stock solution added before HPLC analysis.  
The concentration (conc) of hesperetin standard in each sample was 0.091 mg/mL.  After 
each run, the peak areas from the sample were used to find concentration of individual 
flavonolignans (flav).  The following formula was used to relate flavonolignan peak area, 
IS peak area, and sample weight into flavonolignan concentration: 
conc = (flav peak  area/IS  area) * RF * (1000/sample weight)  
RF is the retention factor of each flavonolignan compound to compensate for 
variation in DAD detection between the internal standard and flavonolignan compounds.  
This was determined for the silybin A & B standard and the taxifolin standard.  All other 
flavonolignans were calculated using the RF from taxifolin. 
(flav standard conc)/(flav peak area) * RF = (IS conc)/(IS peak area) 
Individual flavonolignan identification was accomplished by comparing sample 
peak retention times to retention times of pure standards.  Pure standards used were 
taxifolin, silybin A & B, silydianin, and a silymarin mixture.  Taxifolin, silybin, and 
silymarin standards were obtained from Sigma-Aldrich (St. Louis, MO).  Silydianin was 
obtained from ChromaDex (Irvine, CA).  Previously published chromatographs also 
assisted in conformation. (Wallace et al., 2003) 
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Peak areas were established using manual, base-line integration.  3-D spectra of 
standards and samples assisted in determining peak separation. 
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Procedure D-5: Hesperetin Internal Standard Preparation 
 
These various concentrations of the internal standard were run when deciding 
how much of the internal standard should be added to each sample.  The peak size of the 
internal standard should be on a similar scale as the peak sizes of the compounds of 
interest.  For flavonolignan analysis, 100 µL of 1.0 mg/mL hesperetin stock solution was 
added to each milk thistle seed sample for an internal standard concentration of 0.091 
mg/mL in each sample. 
 
1 µg/µL to 0.01 µg/µL (from Wallace et al. 2003) 
 
1.0 mg/mL 
0.5 mg/mL 
0.1 mg/mL 
0.05 mg/mL 
0.01 mg/mL 
 
1.0 mg/mL 
Weigh 10mg hesperetin into 10mL volumetric flask.   
Add ~ 5mL deionized (di) water.   
Sonicate to dissolve any solids.   
Fill to line. 
 
0.5 mg/mL 
Pipette 1mL of 1.0mg/mL solution into clean glass vial.  Add 4mL di water 
 
0.1 mg/mL 
Pipette 1mL of 0.5mg/mL solution into clean glass vial.  Add 4mL di water 
 
0.05 mg/mL 
Pipette 1mL of 0.1mg/mL solution into clean glass vial.  Add 4mL di water 
 
0.01 mg/mL 
Pipette 1mL of 0.05mg/mL solution into clean glass vial. Add 4mL di water 
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